Next Article in Journal
Purification, Characterization, Prebiotic Preparations and Antioxidant Activity of Oligosaccharides from Mulberries
Next Article in Special Issue
Intramolecular Carbene C-H Insertion Reactions of 2-Diazo-2-sulfamoylacetamides
Previous Article in Journal
Anomeric Spironucleosides of β-d-Glucopyranosyl Uracil as Potential Inhibitors of Glycogen Phosphorylase
Previous Article in Special Issue
Facile Assembling of Novel 2,3,6,7,9-pentaazabicyclo- [3.3.1]nona-3,7-diene Derivatives under Microwave and Ultrasound Platforms
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Novel Synthesis of Substituted 2-Trifluoromethyl and 2-Perfluoroalkyl N-Arylpyridinium Compounds—Mechanistic Insights

1
Laboratoire de Recherche en Chimie Organique et Pharmaceutique, Faculté de Pharmacie et Faculté de Médecine, Université Saint-Joseph (USJ), Rue de Damas, Beirut 11-5076, Lebanon
2
Institut des Biomolécules Max Mousseron, IBMM, UMR 5247, CNRS, Université de Montpellier, ENSCM, c.c.1706, Place E. Bataillon, CEDEX 5, 34095 Montpellier, France
*
Author to whom correspondence should be addressed.
Molecules 2019, 24(12), 2328; https://doi.org/10.3390/molecules24122328
Submission received: 5 June 2019 / Revised: 14 June 2019 / Accepted: 20 June 2019 / Published: 25 June 2019
(This article belongs to the Collection Heterocyclic Compounds)

Abstract

:
We report a new one-pot synthesis of 2-trifluoromethylated/2-perfluoroalkylated N-aryl-substituted pyridiniums, 5,6,7,8-tetrahydroquinoliniums and 6,7,8,9-tetrahydro-5H-cyclohepta[b]-pyridinium compounds starting from an activated β-dicarbonyl analogue (here a perfluoro-alkylated gem-iodoacetoxy derivative), an aromatic amine and a (cyclic or acyclic) ketone. The key step of this multicomponent reaction, involves the formation of a 3-perfluoroalkyl-N,N’-diaryl-1,5-diazapentadiene intermediate, various examples of which were isolated and characterized for the first time, together with investigation of their reactivity. We propose a mechanism involving a concurrent inverse electron demand Diels-Alder or Aza-Robinson cascade cyclisation, followed by a bis-de-anilino-elimination. Noteworthy, a meta-methoxy substituent on the aniline directs the reaction towards a 2-perfluoroalkyl-7-methoxyquinoline, resulting from the direct cyclization of the diazapentadiene intermediate, instead of pyridinium formation. This is the first evidence of synthesis of pyridinium derivatives from activated β-dicarbonyls, ketones, and an aromatic amine, the structures of which (both reactants and products) being analogous to species involved in biological systems, especially upon neurodegenerative diseases such as Parkinson’s. Beyond suggesting chemical/biochemical analogies, we thus hope to outline new research directions for understanding the mechanism of in vivo formation of pyridiniums, hence possible pharmaceutical strategies to better monitor, control or prevent it.

Graphical Abstract

1. Introduction

Compounds containing a pyridinium moiety are important in natural product chemistry [1,2,3,4] and in organic synthesis [5,6,7]. The presence of various substituents, either on the pyridine ring or at the nitrogen atom of the ring, make these important scaffolds versatile compounds used in various areas, ranging from pharmaceutical to industrial chemical applications.
Pyridinium compounds are generally employed as acylating agents [8], phase transfer catalysts [9], dyes [1] and cationic surfactants [9]. 1-Alkylpyridinium derivatives which are liquid at rt., so-called ionic liquids, are potential new solvents for synthesis and catalysis [5]. Pyridinium compounds have been also used to achieve asymmetric and regioselective synthesis by additions of Grignard reagent [10]. Moreover, pyridinium compounds are widely applied as synthetic building blocks to obtain substituted pyridines, dihydropyridines or piperidines [11]. Other N-methyl-pyridinium derivatives have been investigated as new materials, for example, to allow ionic bonding necessary for molecular packing in self-organized solids [12].
On the other hand, quaternary pyridinium derivatives are unsaturated heterocyclic surfactants, generally known for their germicidal properties with a wide range of antimicrobial activity [13,14,15], as well as against some pathogenic species of fungi and protozoa [16].
Also, it was reported that quaternary ammonium compounds react with cell walls and have a direct or indirect lethal effect on the cell [17]. Related quaternary pyridinium derivatives have been tested for anticancer [18], and anti-malarial activity [19,20], and as cholinesterase inhibitors for the treatment of Alzheimer’s disease [21,22,23].
Moreover, pyridinium ions have been incorporated in drug candidates to improve their water solubility [24,25,26]. Otherwise, the use of pyridinium ions bearing lipophilic groups has been shown to improve their accumulation in mitochondria to scavenge or detect radicals generated there [27,28].
Recently, pyridinium amphiphiles were shown to generate promising transfection systems for gene therapy [29,30,31,32]. Several supramolecular pyridinium containing complexes proved to be extremely efficient nucleic acid delivery systems, displaying excellent serum stability and tissue penetration [30,32].
The association of pyridinium derivatives with the appearance of Parkinson’s disease, led to a search for pyridinium analogs as possible endogenous or exogenous neurotoxins critical to this neurodegeneration [33]. For example, 1-methyl-4-phenylpyridinium (MPP+) 1 is the most popular molecule used to induce Parkinsonism in vivo (Scheme 1) [34,35,36]. More recently, pyridinium furosemide (PF) 2, has been also used as a model in helping to identify specific events of Parkinson’s disease [37].
Besides, pyridinium containing compounds are used as herbicides [38,39], drugs [13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32], and as intermediates in the synthesis of many heterocyclic compounds [1,2,3,4,5,6,7,11] and are considered as possible exogenous neurotoxins [40,41,42]. However, several lines of evidence suggest that pyridinium derivatives may be formed under endogenous conditions [43], for example during the Maillard reaction between proteins and carbonyl compounds [43,44,45].

Synthesis of Pyridinium Compounds—A Short Literature Survey

The best-known method for the synthesis of N-(hetero)arylpyridinium salts is the Zincke amine exchange reaction [46,47,48,49,50], which requires a two-step procedure (Scheme 2): First a pyridine 3 is reacted with 1-chloro-2,4-dinitrobenzene (4, X = Cl) to give an N-(2,4-dinitrophenyl)pyridinium chloride 5. This highly electrophilic compound 5 is then reacted with an (hetero)arylamine to give a new N-(hetero)arylpyridinium salt 6 with elimination of 2,4-dinitroaniline [46,47,48,49,50]. This reaction will work best if R is an electron-donor substituent.
Besides, several synthetic routes to N-alkylpyridinium compounds 7 are known, but the most commonly used method is the Menschutkin reaction, an SN2 reaction of a pyridine derivative 3 with an alkyl halide or sulfonate (R’-X) (Scheme 2) [51,52]. This reaction is favored by electron-donor substituents R on the pyridine ring. Moreover, pyridinium salts 6 and 7 are also synthesized from the ring transformation reaction of pyrylium derivatives 8 with primary alkyl or (hetero)arylamines (Scheme 2) [53,54].
Pyridinium compounds may also be synthesized by the Chichibabine reaction [55,56,57,58] based on the [2+2+1+1] approach, involving an acid-mediated reaction between three equivalents of an enolisable aldehyde 9 and one equivalent of amine 10. Typically, three products can be isolated from this reaction (Scheme 3); a major product, 1,2,3,5-tetrasubstituted pyridinium 12, which is formed via the auto-oxidation of the product 1,2,3,5-dihydropyridinium 11, and a minor product 1,3,5-trisubstituted pyridinium derivative 13. However, the Chichibabine reaction requires harsh conditions, give low yields with numerous difficult to separate side products [57,58].
In previous articles [59,60,61,62,63,64,65] we have reported the synthesis of various perfluoroalkylated quinoline derivatives, by reacting perfluoroalkylated gem-iodoacyloxy derivatives 14 with substituted anilines 15. Later we observed that the presence of a ketone in the medium leads to the formation of arylpyridiniums instead of quinolines; what suggested an interesting alternative to published synthetic methods, and led us to design a new and efficient synthesis of substituted 2-trifluoromethyl and 2-perfluoroalkyl-N-arylpyridinium derivatives 1719 under mild reaction conditions and with very good yields. Mechanistic studies addressing possible intermolecular cycloaddition reactions are detailed, underlying possible chemical/biochemical mechanistic analogies in relation to the formation of pyridinium derivatives under biological conditions.

2. Results and Discussion

2.1. Synthesis

We report the reaction of 1-acetoxy-2-(perfluoroalkyl)-1-iodo-ethane 1414” and various anilines 15a-n in the presence of acetone 16t (R1 = CH3, R2 = H), leading to the formation of 2-trifluoromethyl and 2-perfluoroalkyl-6-methyl-N-arylpyridinium derivatives 17an’ in fair to excellent yields (50–90%) (Scheme 4, Table 1). This reaction was then exemplified using two cyclic ketones, namely cyclohexanone 16u and cycloheptanone 16v, both of which reacted smoothly to give the corresponding 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-5,6,7,8-tetrahydroquinoliniums 18an (R1-R2 = -(CH2)4-; Table 2) in good to excellent yields (75–90%) and 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums 19am (R1–R2 = -(CH2)5-; Table 3), respectively. All reactions proceeded with good to very good yields (70–90%).
The numbering scheme for the investigated examples in compound series 1719, is the following: (i) the numbers 1719 denote the compound series depending on the reacting ketone 16tv; (ii) the letter an denotes the aryl substituent inherited from the aniline substrate 15; (iii) the appended or denotes the perfluoroalkyl chain RF from perfluoroalkyl substrate 14: RF = C5F11 (14), CF3 (14’) or C3F7 (14”) respectively. For instance, 17a is obtained from 15a and 14, or 17n’ is obtained from 15n and 14’.
Thorough screening of reactants stoichiometries and reaction conditions (monitoring by TLC and 19F-NMR spectroscopy), allowed us to identify optimized conditions giving the best overall yields: namely one equivalent of gem-iodoacetate 1414”, three equivalents of arylamine 15a–o and 1.2 equivalents of ketone 16tv in refluxing anhydrous dichloromethane. Reactions were typically completed within 4–12 h. A straightforward work-up allowed the isolation of pyridinium products 1719, through: (i) filtering off the excess anilinium salts that precipitated at the end of the reaction, then (ii) precipitating the product from the filtrate by addition of an appropriate solvent. Further purification of 1719 was carried out by final precipitation from dichloromethane-ether mixture, pure 2-perfluoroalkyl-N-arylpyridinium iodides 1719 being isolated as amorphous solids.

2.2. Structure Determination of N-Arylpyridiniums 1719

Structural assignments were accomplished without ambiguity by 1H-, 13C- and 19F-NMR as well as 2D 1H-1H (COSY) and 1H-13C (HETCOR) NMR correlations. As an example, the NMR spectra of 6-methyl-2-perfluoropentyl-1-phenylpyridinium 17a (R = R2 = H, R1 = CH3, RF = C5F11) (Figure 1) are typical and will be described in details: the 1H- and 13C-NMR spectra contain six and ten distinct resonances, respectively (see 1D 1H and 13C-NMR in Supplementary Materials).
In its 1H-NMR spectrum, the singlet at δH 2.6 ppm (3H) is readily assigned to the methyl group which show a cross peak with the 13C resonance at δC 25 ppm in the 1H-13C HETCOR chart. Noticeably, upon shaking the samples dissolved in CDCl3 with one droplet of D2O, the methyl resonance of 17a readily disappears from the 1H spectrum, denoting a rapid H/D exchange which is explained by the acidic character of the protons on alkyl substituents of the pyridinium ring.
1H resonances corresponding to the N-phenyl moiety, are divided into two groups: first a 3H multiplet is observed at δH 7.5–7.6 ppm corresponding to the Hm and Hp on the meta- and para- positions. Then, a slightly deshielded doublet resonance at δH 7.7 ppm corresponds to the two Ho protons at ortho- positions. On the HETCOR chart, the meta- and para-hydrogens resonances show cross peaks with 13C resonances at δC 130.5 and 132.5 ppm, while the ortho- proton resonance also show a clear cross peak with the 13C resonance at δC 126.7 ppm.
Besides, the most deshielded resonances at δH 8.3, 8.7 and 9.1 ppm, were assigned to the three vicinal hydrogen atoms on the pyridinium nucleus (H3, H4 and H5) (Figure 1 and 1D 1H-NMR in Supporting Information). This can be confirmed in the 1H-1H COSY chart where clear cross peaks between those three resonances at δH 8.3, 8.7 and 9.1 ppm are observed. Moreover, those resonances exhibit 3JH–H couplings constants of ca. 8–8.1 Hz characteristic of aromatic hydrogens.
Among them, the most deshielded resonance (δH 9.1 ppm) is a triplet signal, thus corresponding to H4, due to vicinal couplings with two neighboring protons H3/H5 the resonances of which indeed appear as two doublets at δH 8.3 and 8.7 ppm, which correlate with 13C resonances at δC 128.8 and 136.2 ppm respectively on the HETCOR chart. The final assignment between H3 and H5 was made on basis of the presence of a 2.5 Hz triplet coupling on the 128.8-ppm 13C resonance explained as a 3JCFcoupling with fluorine nuclei on the vicinal CF2 group; thus both signals δH 8.3 ppm and δC 128.8 ppm belong to the H3/C3 position of the pyridinium ring, while the δH 8.7 ppm and δC 136.2 ppm corresponds to H5/C5.
Three additional 13C resonances in the aromatic shift range, correspond to quaternary carbons (invisible on DEPT spectra): the signal at δC 140.8 ppm appearing as a large triplet denotes a strong coupling with fluorine nuclei of vicinal CF2 group (2JCF = 26.3 Hz), thus can nonambiguously be attributed to carbon C2. Besides, on basis of a higher deshielding by the pyridinium ring, the two other resonances at δC 163.8 and 137.8 ppm, were assigned to the carbon C6 and the ipso carbon of the N-phenyl, respectively (Figure 1).
Interestingly, we also observed a large deshielding of the 19F-NMR resonance of the α-CF2 directly attached to the pyridinium ring, probably because of the high electron-withdrawing effect of the adjacent positively charged nitrogen atom. This was similarly observed on the whole series of perfluoroalkyl-substituted pyridiniums 1719.

2.3. The m-Anisidine Case

A notable exception to the above synthesis results, was observed however with a meta-methoxy substitution on substrate 15o (m-anisidine) where the only observed and isolated product was the corresponding 2-perfluoroalkyl- or 2-trifluoromethyl-7-methoxyquinolines 20o (RF = C5F11) or 20o’ (RF = CF3) in 80–90% yields (Scheme 5 and Table 4); while the ketone 16 was recovered at the end of the reaction (isolated and identified by NMR and mass spectrometry). In the absence of ketone 16 (namely upon reacting 14/14’ with three equivalents of 15o under identical conditions) the same result was observed with similar yields of 20, what is actually consistent with our previous investigations on such reactions [64].

2.4. Reactivity Investigation—Intermediate Isolation

Based on the observed reaction extents and required time for completion according to the substituents (Table 1, Table 2 and Table 3), this series of investigated examples provided preliminary insights on the reactivity of the system, where a primary factor of influence is likely the substitution of aniline 15. For instance, the presence of an electron-withdrawing group on the aromatic ring of 15 resulted in longer reaction times being required to reach completion, as observed e.g., with R = Cl or CO2H at any o-, m-, p- position (Table 1, entries 12–14, 17–20; Table 2 entries 7, 9, 10; Table 3, entries 6–7, 10). An ortho-substituted aniline 15 also resulted in an extended reaction time, whenever the o-substituent was electron-donating or electron-withdrawing (R = o-Me, o-Et, o-OMe, o-Cl and o-CO2H; Table 1, entries 4, 8, 12, 15, 17–18; Table 2, entries 3, 9; Table 3, entries 8, 10).
In order to better understand the mechanism of this reaction, its evolution was monitored by 19F-NMR spectroscopy, carried out on aliquots of the reaction medium diluted in CDCl3 or DMSO-d6, then comparing the spectra of reaction mixtures with NMR data of compounds already investigated and characterized in the course of our previous studies on gem-iodoacetoxy related systems [59,60,61,62,63,64,65].
We thus observed that the consumption of the starting 1-acetoxy-1-iodo-2-(perfluoroalkyl)-ethanes 1414” was accompanied by the formation of an intermediate compound, the latter further disappeared while the final 2-perfluoroalkyl-N-arylpyridinium products 1719 were gradually formed. Comparison with our previous NMR data provided fair assumption that such intermediate might be an N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapenta-1,3-diene 21 (Scheme 6), a few examples of which had previously been described by us [59,63,64].
In the absence of ketone 16 as reactant, and upon changing the other reactant stoichiometries to those stated in our previous works [64] namely 1 equiv. 1414” and 2 equiv. 15 (in DCM at rt: 21al,oo’; or refluxing: 21m–n’), the main reaction product was the intermediate 21, the latter (21ao’) have been isolated in fair yields then characterized by NMR and mass spectrometry (Scheme 6). All N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapenta-1,3-dienes 21ao’ were actually isolated as mixtures of E/Z-stereoisomers, as in our previous works [59,64,65].

2.5. Reactivity of Diazapentadienes 21

We then investigated the reactivity of diazapentadienes intermediates 21ao’ in the presence of ketones 16ac, where we noticed that the presence of an additional amount of aniline 15 is necessary to achieve pyridinium 1719 formation. Thus, upon reacting isolated intermediates 21 with 1.2 equivalents of ketone 16 and one equivalent of arylamine 15 (the same substitution as used in the formation of 21) in the presence of hydrogen iodide in refluxing dichloromethane, the consumption of 21 (monitored by TLC and 19F-NMR spectroscopy) was accompanied with the formation of the corresponding 2-perfluoroalkyl-N-arylpyridiniums 1719. Noteworthy from a reactivity/mechanistic viewpoint, to our knowledge this is the first experimental evidence of the formation of arylpyridinium compounds from an N,N’-diaryl-1,5-diazapenta-1,3-diene intermediate.
In the m-methoxy case (substrate 15o), while the derived diazapentadiene intermediate 21o/o’ was formed and isolated under identical conditions and with same yields as other examples a-n, the subsequent reaction of isolated 21o/o’ in the presence of ketone 16 under the same conditions (one equiv. 15o under acidic conditions), formed the 2-perfluoroalkyl-7-methoxyquinolines 20o/o’ as the only products (Scheme 6, lower path), a result actually identical to the reaction of 21o/o’ with 15 in the absence of ketone [64].
Based on required reactant stoichiometry, the mechanism of the reactions may be rationalized as follows (Scheme 7). In a first step, the gem-iodoacetoxy substrate 14/14” reacts with two equivalents of arylamine 15 to form the corresponding diazapentadiene 21, according to our previously reported investigations [64]. Meanwhile, another equivalent of arylamine 15 may condense with ketone 16 through an acid catalyzed, addition-elimination mechanism to give a tautomeric N-phenyl-imino/enamine intermediate 22 (Scheme 7). Then, the resulting intermediates 21 and 22 may react together through two probably competing cyclization cascade mechanisms [66,67,68,69,70]: either: (i) an inverse electron demand Diels-Alder (IEDDA) reaction involving the cycloaddition of the diene 21 and the electron-rich dienophile 22, or (ii) an aza-Robinson annulation-type reaction involving a Michaël addition of enamine 22 to diazapentadienes 21 then subsequent aminal-cyclisation. Both mechanisms could give a bis-anilinotetrahydropyridine (BATHP) intermediate 23. The latter then undergoes a double de-anilino-elimination, thus yielding the corresponding N-arylpyridinium iodides 1719 (Scheme 7).

2.6. Formation of 2-Perfluoroalkyl-7-Methoxyanilines 20o–o’

The key step of this mechanism is the protonation of 21o and the formation of a conjugated iminium intermediate (Scheme 8). Then Michael addition of m-methoxyaniline 15o gives a cationic bis-anilino intermediate which undergo an intramolecular electrophilic aromatic cyclisation assisted by the electron-donating methoxyl group with subsequent elimination of a m-methoxyaniline. Then a prototropy induced by anilino-group followed by the loss of a proton and a second m-methoxyaniline result in the generation of an aromatic ring and the formation of 2-perfluoroalkyl-7-methoxyanilines 20oo’.
Conversely in the case of an m-methoxy substituted arylamine, the electron-donation ability of the methoxy- substituent on the N,N’-(3-methoxyphenyl)-2-(perfluoroalkyl)-1,5-diazapentadienes 21oo’, may promote their direct intramolecular cyclization to 20 (Scheme 8) [59,64], the latter route also taking advantage of an entropically favorable (unimolecular) cyclization over a bimolecular addition of 21oo’ with 22o.
Indeed, the literature [71] states that electronic and steric effects of substituents have very pronounced influence on both intermolecular Michaël 1,4-additions or Diels-Alder cycloadditions. Many studies show that stereoelectronic requirements for certain intermolecular reaction and the resulting increase in the potential energy for the corresponding transition states, could be so high that intramolecular cyclisation could take place instead [71]. In both cases anyway (either cycloaddition or cyclization), the subsequent elimination of two aniline molecules, may ensure irreversibility, again because of entropic effects.

3. Materials and Methods

3.1. General Methods

All reaction solvents were purchased from commercial suppliers and distilled before use. All synthetic reactions were performed in oven-dried glassware, and their progress was monitored by thin layer chromatography (TLC) using silica gel plates, and by 19F-NMR spectroscopy of aliquots. Chromatographic column purifications were performed on silica gel (40–63 μm). 1H, 13C, and 19F-NMR spectra were recorded in either CDCl3 or DMSO-d6 solution on an Avance 300 (300 MHz) or an Avance 400 (400 MHz) spectrometer (Bruker, Billerica, MA, USA). Chemical shifts are reported in ppm, using the solvent signal chemical shift as a reference. Abbreviations used in the description of NMR spectra: s: singlet, d: doublet, t: triplet, q: quadruplet, bs: broad signal. Coupling constants (J) are given in Hertz. Mass spectra (either low- or high-resolution) were recorded on a SX102 mass spectrometer (JEOL, Tokyo, Japan) in FAB+ mode, using 3-nitrobenzyl alcohol matrix. Elemental analyses were carried out on a Flash 2000 elemental analyzer (Thermo Finnigan, Waltham, MA, USA).

3.2. General Procedure for the Synthesis 2-Trifluoromethylated and 2-Perfluoroalkylated 6-Methyl-N-(R-Phenyl)Pyridinium Iodides (17al), N-(R-Phenyl)-5,6,7,8-Tetrahydroquinolinium Iodides (18al) and N-(R-Phenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[B]Pyridinium Iodides (19al) (All examples except R = CO2H or R = M-Ome)

To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 (1 equiv.) in anhydrous dichloromethane (10 mL DCM for 1g of 14), was added 3 equiv. of the corresponding substituted aniline 15 and 1.2 equiv. of ketone 16. The mixture was stirred under reflux for the desired time (4–12 h, Table 1, Table 2 and Table 3) until complete consumption of 14 (monitored by TLC eluent petroleum ether/ethyl acetate: 80/20 v/v and 19F-NMR spectroscopy of aliquots). When the reaction was completed, the mixture was allowed to cool to r.t. then the brown precipitate accumulated during the reaction was separated by vacuum filtration (it was subsequently identified as anilinium salts by NMR and MS). Then ethyl ether was added to the filtrate and the corresponding pyridinium iodides 17al, 18al, and 19al precipitate instantly and were isolated by vacuum filtration as amorphous solids.
2-Perfluoropentyl-6-methyl-N-phenylpyridinium iodide (17a). Aniline 15a (5.24 g, 5.63 × 10−2 mole) and acetone (16t, 1.65 mL, 1.3 g, 2.25 × 10−2 mole) were added to a solution of 14 (RF = C5F11, 10 g, 1.87 × 10−2 mole) in dry dichloromethane (100 mL). The mixture was stirred for 2 h at reflux to afford 9.55 g of the title product 17a, total yield 90%. 1H-NMR (400.13 MHz, CDCl3) δ 2.6 (s, 3H, CH3), 7.5–7.6 (m, 3H, Ph-H), 7.7 (d, J = 7.1 Hz, 2H, Ph-H), 8.3 (d, J = 8 Hz, 1H, Py-H), 8.7 (d, J = 8 Hz, 1H, Py-H), 9.1 (t, J = 8.1 Hz, 1H, Py-H); 1H-NMR (400.13 MHz, CDCl3+D2O) δ 7.5–7.6 (m, 3H, Ph-H), 7.7 (d, J = 7.2 Hz, 2H, Ph-H), 8.3 (d, J = 8 Hz, 1H, Py-H), 8.7 (d, J = 8.1 Hz, 1H, Py-H), 9.1 (t, J = 8.1 Hz, 1H, Py-H); 13C-NMR (100.6 MHz, CDCl3) δ 25 (s, CH3), 126.7, 128.8 (t, 3JCF = 2.5 Hz), 130.4, 132.5, 136.2, 137.8, 140.8 (t, 2JCF = 26.3 Hz), 148, 163.8; 19F-NMR (235.3 MHz, CDCl3) δ −126.5 (m 2F, CF2-CF2-CF2-CF2-CF3), −123 (m 2F, CF2-CF2-CF2-CF2-CF3), −118 (m 2F, CF2-CF2-CF2-CF2-CF3), −102.5 (m 2F, CF2-CF2-CF2-CF2-CF3), −81.5 (m 3F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 438 ([M − I]+, 100). HRMS calcd. for C17H11F11N+ 438.0716, found 438.0720. Anal. Calcd. for C17H11F11NI: C, 36.13; H, 1.96; N, 2.48. Found: C, 36.15; H, 1.95; N, 2.46.
2-Trifluoromethyl-6-methyl-N-phenylpyridinium iodide (17a’). Aniline 15a (8.4 g, 9 × 10−2 mol) and acetone (16t, 2.7 mL, 2 g, 3.61 × 10−2 mol) were added to a solution of 14’ (RF = CF3, 10 g, 3 × 10−2 mol) in dry dichloromethane (100 mL). The mixture was stirred for 2 h at reflux to give 9.9 g of the title product 17a’, total yield 90%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 2.6 (s, 3H, CH3), 7.5–7.6 (m, 3H), 7.8 (d, J = 9 Hz, 2H), 8.5 (dd, J = 9 and 3 Hz, 1H), 8.6 (dd, J = 9 and 3 Hz, 1H), 9 (t, J = 9 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 24.1 (s, CH3), 118.6 (q, CF3, 1JCF = 276.9 Hz), 125.6 (q, 3JCF = 5.2 Hz), 125.7, 130.1, 132.3, 135.1, 136.7, 140.9 (q, C-CF3, 2JCF = 35.4 Hz), 148, 162.5; 19F-NMR (282.4 MHz, CDCl3) δ −59.8 (s 3F, CF3). MS (m/z): 238 ([M − I]+, 100). HRMS calcd. for C13H11F3N+: 238.0844, found 238.0848. Anal. Calcd. for C13H11F3NI: C, 42.76; H, 3.04; N, 3.84. Found: C, 42.78; H, 3.05; N, 3.82.
2-Perfluoropropyl-6-methyl-N-phenylpyridinium iodide (17a’’). Aniline 15a (6.45 g, 6.94 × 10−2 mol) and acetone (16t, 1.6 mL, 2 g, 2.77 × 10−2 mol) were added to a solution of 14’’ (RF = C3F7, 10 g, 2.31 × 10−2 mol) in dry dichloromethane (100 mL). The mixture was stirred for 2 h at reflux, affording 9.69 g of the title product 17a’’, total yield 91%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.6 (s, 3H, CH3), 7.5–7.6 (m, 3H), 7.7 (d, J = 7 Hz, 2H), 8.3 (d, J = 8.1 Hz, 1H), 8.8 (d, J = 8 Hz, 1H), 9 (t, J = 8 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 25.1 (s, CH3), 126.5, 128.7 (t, 3JCF = 2.5 Hz), 130.4, 132.2, 136.1, 137.7, 140.9 (t, 2JCF = 26.5 Hz), 148, 163.7; 19F-NMR (235.3 MHz, CDCl3) δ −127 (m 2F, CF2), −102 (m 2F, CF2), −80.5 (m 3F, CF3). MS (m/z): 338 ([M − I]+, 100). HRMS calcd. for C15H11F7N+: 338.0780, found 338.0782. Anal. Calcd. for C15H11F7NI: C, 38.73; H, 2.38; N, 3.01. Found: C, 38.75; H, 2.39; N, 3.04.
2-Perfluoropentyl-6-methyl-N-(2-methylphenyl)pyridinium iodide (17b). 2-Methylaniline (15b, 6 g, 5.63 × 10−2 mol) and acetone (16t, 1.66 mL, 1.3 g, 2.25 × 10−2 mol) were added to a solution of 14 (RF = C5F11, 10 g, 1.87 × 10−2 mol) in dry dichloromethane (100 mL). The mixture was stirred for 4 h at reflux, to give 8.7 g of the title product 17b, total yield 80%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.5 (s, 3H, CH3), 2.6 (s, 3H, CH3), 7.4–7.6 (m, 4H), 7.9 (t, J = 7.2 Hz, 1H), 8.2 (d, J = 8.1 Hz, 1H), 8.9 (d, J = 8.2 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 20.1 (s, CH3), 25 (s, CH3), 127, 128.5 (t, 3JCF = 2 Hz), 130.5, 131.9, 136.1, 138, 141.1 (t, 2JCF = 26 Hz), 148, 163.5; 19F-NMR (282.4 MHz, CDCl3) δ −125.7 (m 2F, CF2), −122.1 (m 2F, CF2), −118.2 (AB system, 2JFF = 338.8 Hz, 1F, CF2-CF2-CF2), −116 (AB system, 2JFF = 338.8 Hz, 1F, CF2-CF2-CF2), −108.5 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2), −98 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2), −80.6 (m 3F, CF3). MS (m/z): 452 ([M − I]+, 100). HRMS calcd. for C18H13F11N+: 452.0872, found 452.0877. Anal. Calcd. for C18H13F11NI: C, 37.33; H, 2.26; N, 2.42. Found: C, 37.35; H, 2.30; N, 2.40.
2-Perfluoropentyl-6-methyl-N-(3-methylphenyl)pyridinium iodide (17c). 3-Methylaniline (15c, 6.34 g, 5.92 × 10−2 mol) and acetone (16t, 1.75 mL, 1.37 g, 2.36 × 10−2 mol) were added to a solution of 14 (RF = C5F11, 0.5 g, 1.97 × 10−2 mol) in dry dichloromethane (105 mL). The mixture was stirred for 4 h at reflux to give 9.7 g of the title product 17c, total yield 85%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.6 (s, 3H, CH3), 2.7 (s, 3H, CH3), 7.4–7.6 (m, 4H), 8.3 (d, J = 7.2 Hz, 1H), 8.8 (d, J = 8.1 Hz, 1H), 9.2 (t, J = 8.1 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 22 (s, CH3), 26 (s, CH3), 121, 123, 128 (t, 3JCF = 2 Hz), 130.5, 132, 136.1, 137, 139 (t, 2JCF = 25 Hz), 145, 148, 161; 19F-NMR (282.4 MHz, CDCl3) δ −126 (s 2F, CF2), −122.4 (s 2F, CF2), −117.2 (s 2F, CF2), −103.5 (AB system, 2JFF = 310.6 Hz, 1F, CF2-CF2), −101.1 (AB system, 2JFF = 310.6 Hz, 1F, CF2-CF2), −80.7 (m 3F, CF3). MS (m/z): 452 ([M − I]+, 95). HRMS calcd. for C18H13F11N+: 452.0872, found 452.0875. Anal. Calcd. for C18H13F11NI: C, 37.33; H, 2.26; N, 2.42. Found: C, 37.36; H, 2.28; N, 2.40.
2-Perfluoropentyl-6-methyl-N-(4-methylphenyl)pyridinium iodide (17d). 4-Methylaniline (15d, 5.74 g, 5.35 × 10−2 mol) and acetone (16t, 1.58 mL, 1.24 g, 2.14 × 10−2 mol) were added to a solution of 14 (RF = C5F11, 9.5 g, 1.78 × 10−2 mol) in dry dichloromethane (95 mL). The mixture was stirred for 4 h at reflux to afford 8.79 g of the title product 17d, total yield 85%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.65 (s, 3H, CH3), 2.7 (s, 3H, CH3), 7.4 (d, J = 8 Hz, 2H), 7.7 (d, J = 8 Hz, 2H), 8.3 (d, J = 8.2 Hz, 1H), 8.8 (d, J = 8.3 Hz, 1H), 9 (t, J = 8.2 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 25 (s, CH3), 26.1 (s, CH3), 122.7, 126.5, 127.7 (t, 3JCF = 1.5 Hz), 129.9, 130, 135.1, 137.8 (t, 2JCF = 27.2 Hz), 142.5, 146.6, 150.2, 167.5; 19F-NMR (282.4 MHz, CDCl3) δ −126 (s 2F, CF2), −122.4 (s 2F, CF2), −117.2 (s 2F, CF2), −101.6 (s, 2F, CF2-CF2), −80.7 (m 3F, CF3). MS (m/z): 452 ([M − I]+, 100). HRMS calcd. for C18H13F11N+: 452.0872, found 452.0878. Anal. Calcd. for C18H13F11NI: C, 37.33; H, 2.26; N, 2.42. Found: C, 37.37; H, 2.26; N, 2.39.
2-Trifluoromethyl-6-methyl-N-(4-methylphenyl)pyridinium iodide (17d’). 4-Methylaniline (15d, 8.81 g, 8.22 × 10−2 mol) and acetone (16t, 2.43 mL, 1.9 g, 3.28 × 10−2 mol) were added to a solution of 14’ (RF = CF3, 9.1 g, 2.74 × 10−2 mol) in dry dichloromethane (91 mL). The mixture was stirred for 4 h at reflux to yield 9.14 g of the title product 17d’, total yield 88%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.6 (s, 3H, CH3), 2.7 (s, 3H, CH3), 7.4 (d, J = 8.1 Hz, 2H), 7.7 (d, J = 8 Hz, 2H), 8.3 (d, J = 8 Hz, 1H), 8.7 (d, J = 8.1 Hz, 1H), 9.2 (t, J = 8.1 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 24.2 (s, CH3), 25 (s, CH3), 118.4 (q, CF3, 1JCF = 276.8 Hz), 124.8 (q, 3JCF = 5 Hz), 122.5, 125.6, 130, 132.3, 140.9 (q, C-CF3, 2JCF = 36 Hz), 147.2, 150, 162.5; 19F-NMR (282.4 MHz, CDCl3) δ −59.9 (s 3F, CF3). MS (m/z): 252 ([M − I]+, 95). HRMS calcd. for C14H13F3N+: 252.100, found 252.1010. Anal. Calcd. for C14H13F3NI: C, 44.35; H, 3.46; N, 3.69. Found: C, 44.38; H, 3.47; N, 3.70.
2-Perfluoropentyl-6-methyl-N-(2-ethylphenyl)pyridinium iodide (17e). 2-Ethylaniline (15e, 7 g, 5.8 × 10−2 mol) and acetone (16t, 1.7 mL, 1.34 g, 2.32 × 10−2 mol) were added to a solution of 14 (RF = C5F11, 10.3 g, 1.93 × 10−2 mol) in dry dichloromethane (103 mL). The mixture was stirred for 6 h at reflux to produce 8 g of the title product 17e, total yield 70%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.6 (q, J = 8 Hz, 2H, CH2-CH3), 2.8 (s, 3H, CH3), 7.4–7.6 (m, 3H), 8 (s, 1H), 8.2 (d, J = 8 Hz, 1H), 8.9 (d, J = 8.1 Hz, 1H); 9.2 (t, J = 8.1 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 13.2 (s, CH2-CH3), 24.3 (s, CH2-CH3), 27.1 (s, CH3), 124.2, 125.9, 127.8 (t, 3JCF = 2.1 Hz), 129.6, 131, 136.1, 137.5 (t, 2JCF = 25 Hz), 146.5, 150.1, 167.7; 19F-NMR (282.4 MHz, CDCl3) δ −126 (m 2F, CF2), −122.9 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.8 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −118.7 (AB system, 2JFF = 300.9 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −115.9 (AB system, 2JFF = 300.9 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −108.5 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −98.8 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.7 (m 3F, CF3). MS (m/z): 466 ([M − I]+, 95). HRMS calcd. for C19H15F11N+: 466.1029, found 466.1033. Anal. Calcd. for C19H15F11NI: C, 38.47; H, 2.55; N, 2.36. Found: C, 38.48; H, 2.56; N, 2.40.
2-Perfluoropentyl-6-methyl-N-(3-ethylphenyl)pyridinium iodide (17f). 3-Ethylaniline (15f, 7.17 g, 5.92 × 10−2 mol) and acetone (16t, 1.75 mL, 1.37 g, 2.36 × 10−2 mol) were added to a solution of 14 (RF = C5F11, 10.5 g, 1.97 × 10−2 mol) in dry dichloromethane (105 mL). The mixture was stirred for 4 h at reflux to obtain. 9.36 g of the title product 17f, total yield 80%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.7 (s, 3H, CH3), 2.8 (q, J = 8 Hz, 2H, CH2-CH3), 7.4–7.7 (m, 4H), 8.4 (d, J = 6.7 Hz, 1H), 8.9 (d, J = 7.1 Hz, 1H), 9.2 (t, J = 7.9 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 13 (s, CH2-CH3), 23 (s, CH2-CH3), 27 (s, CH3), 121.5, 123.5, 127 (t), 128, 130, 134, 135, 139 (t, 2JCF = 25 Hz), 145, 146, 162; 19F-NMR (282.4 MHz, CDCl3) δ −126 (s 2F, CF2), −122.4 (s 2F, CF2), −117.2 (s 2F, CF2), −102.5 (AB system, 2JFF = 315.5 Hz, 1F, CF2-CF2), −101.5 (AB system, 2JFF = 315.5 Hz, 1F, CF2-CF2), −80.7 (m 3F, CF3). MS (m/z): 466 ([M − I]+, 100). HRMS calcd. for C19H15F11N+: 466.1029, found 466.1035. Anal. Calcd. for C19H15F11NI: C, 38.47; H, 2.55; N, 2.36. Found: C, 38.49; H, 2.56; N, 2.33.
2-Perfluoropentyl-6-methyl-N-(4-ethylphenyl)pyridinium iodide (17g). 6.9 g of 4-ethylaniline 15g (5.69 × 10−2 mol) and 1.68 mL or 1.32 g (2.27 × 10−2 mol) of acetone 16t were added to a solution of 10.1 g (1.89 × 10−2 mol) of 14 (RF = C5F11) in 101 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9.34 g of the title product 17g were obtained, total yield 83%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.7 (s, 3H, CH3), 2.8 (q, J = 8 Hz, 2H, CH2-CH3), 7.1 (d, J = 8.4 Hz, 2H), 7.7 (d, J = 8.3 Hz, 2H), 8.4 (d, J = 7.5 Hz, 1H), 8.8 (d, J = 7.8 Hz, 1H), 9.1 (t, J = 7.8 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 13 (s, CH2-CH3), 24 (s, CH2-CH3), 26.8 (s, CH3), 113.5, 126.5, 127.5 (t, 3JCF = 2 Hz), 129.5, 130, 135, 139 (t, 2JCF = 25 Hz), 147, 159, 162; 19F-NMR (282.4 MHz, CDCl3) δ −126.9 (s 2F, CF2), −123.3 (s 2F, CF2), −117.3 (s 2F, CF2), −101.8 (s, 2F, CF2-CF2), −80.7 (m 3F, CF3). MS (m/z): 466 ([M − I]+, 100). HRMS calcd. for C19H15F11N+: 466.1029, found 466.1030. Anal. Calcd. for C19H15F11NI: C, 38.47; H, 2.55; N, 2.36. Found: C, 38.48; H, 2.56; N, 2.35.
2-Trifluoromethyl-6-methyl-N-(4-ethylphenyl)pyridinium iodide (17g’). 9.85 g of 4-ethylaniline 15g (8.13 × 10−2 mol) and 2.4 mL or 1.88 g (3.25 × 10−2 mol) of acetone 16t were added to a solution of 9 g (2.71 × 10−2 mol) of 14’ (RF = CF3) in 90 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9 g of the title product 17g’ were obtained, total yield 85%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.7 (s, 3H, CH3), 2.8 (q, J = 8 Hz, 2H, CH2-CH3), 7.1 (d, J = 8 Hz, 2H), 7.7 (d, J = 8 Hz, 2H), 8.2 (d, J = 8 Hz, 1H), 8.7 (d, J = 8 Hz, 1H), 9 (t, J = 8.1 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 13.2 (s, CH2-CH3), 23.9 (s, CH2-CH3), 27 (s, CH3), 118.1 (q, CF3, 1JCF = 277.6 Hz), 125 (q, 3JCF = 4.8 Hz), 122.4, 125.7, 130.2, 132, 147.2 (q, C-CF3, 2JCF = 35.5 Hz), 149.9, 162; 19F-NMR (282.4 MHz, CDCl3) δ −58.9 (s 3F, CF3). MS (m/z): 266 ([M − I]+, 100). HRMS calcd. for C15H15F3N+: 266.1157, found 266.1160. Anal. Calcd. for C15H15F3NI: C, 45.82; H, 3.85; N, 3.56. Found: C, 45.85; H, 3.86; N, 3.52.
2-Perfluoropentyl-6-methyl-N-(2-chlorophenyl)pyridinium iodide (17h). 7.4 g of 2-chloroaniline 15h (5.8 × 10−2 mol) and 1.7 mL or 1.34 g (2.32 × 10−2 mol) of acetone 16t were added to a solution of 10.3 g (1.93 × 10−2 mol) of 14 (RF = C5F11) in 103 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 6.96 g of the title product 17h were obtained, total yield 60%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.8 (s, 3H, CH3), 7.7–7.9 (m, 3H), 8.4 (m, 1H), 8.5 (d, J = 8 Hz, 1H), 8.9 (d, J = 8.1 Hz, 1H); 9.4 (t, J = 8 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 24.2 (s, CH3), 128.5, 129.1, 130.1, 130.8, 133.8, 135, 136.2, 140.5 (t, 2JCF = 24.1 Hz), 148.8, 163.8; 19F-NMR (282.4 MHz, CDCl3) δ −126.5 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.7 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −122.9 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.6 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −118.7 (AB system, 2JFF = 299.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −115.9 (AB system, 2JFF = 299.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −108.2 (AB system, 2JFF = 288.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −98.8 (AB system, 2JFF = 288.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.7 (m 3F, CF3). MS (m/z): 472 ([M − I]+, 90). HRMS calcd. for C17H10ClF11N+: 472.0326, found 472.0329. Anal. Calcd. for C17H10ClF11NI: C, 34.05; H, 1.68; N, 2.34. Found: C, 34.08; H, 1.67; N, 2.33.
2-Perfluoropentyl-6-methyl-N-(3-chlorophenyl)pyridinium iodide (17i). 7.55 g of 3-chloroaniline 15i (5.92 × 10−2 mol) and 1.75 mL or 1.37 g (2.36 × 10−2 mol) of acetone 16t were added to a solution of 10.5 g (1.97 × 10−2 mol) of 14 (RF = C5F11) in 105 mL of dry dichloromethane. The mixture was stirred for 6 h at reflux. 8.28 g of the title product 17i were obtained, total yield 70%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.7 (s, 3H, CH3), 7.3 (s, 1H), 7.4–7.6 (m, 2H), 7.7 (m, 1H), 8.3 (d, J = 8 Hz, 1H), 8.5 (d, J = 8 Hz, 1H), 8.8 (t, J = 8 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 27.3 (s, CH3), 127.9, 129.6, 131.4, 134.1, 135.5, 138.5 (t, 2JCF = 25 Hz), 141.1, 150.6, 166.4; 19F-NMR (282.4 MHz, CDCl3) δ −121.5 (s 2F, CF2), −117.5 (s 2F, CF2), −112.7 (s 2F, CF2), −97.4 (AB system, 2JFF = 105.3 Hz, 1F, CF2-CF2), −97.1 (AB system, 2JFF = 105.3 Hz, 1F, CF2-CF2), −75.9 (m 3F, CF3). MS (m/z): 472 ([M − I]+, 90). HRMS calcd. for C17H10ClF11N+: 472.0326, found 472.0330. Anal. Calcd. for C17H10ClF11NI: C, 34.05; H, 1.68; N, 2.34. Found: C, 34.11; H, 1.65; N, 2.36.
2-Perfluoropentyl-6-methyl-N-(4-chlorophenyl)pyridinium iodide (17j). 7.19 g of 4-chloroaniline 15j (5.63 × 10−2 mol) and 1.66 mL or 1.3 g (2.25 × 10−2 mol) of acetone 16t were added to a solution of 10 g (1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for 6 h at reflux. 9.58 g of the title product 17j were obtained, total yield 85%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 2.5 (s, 3H, CH3), 7.9 (d, J = 8 Hz, 2H), 8.2 (d, J = 8.1 Hz, 2H), 8.6 (d, J = 8 Hz, 1H), 8.8 (d, J = 7.9 Hz, 1H), 9 (t, J = 7.9 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 26 (s, CH3), 113.2, 126, 127.4 (t, 3JCF = 2.2 Hz), 130.2, 136, 139.2 (t, 2JCF = 24.8 Hz), 147.2, 158, 162.3; 19F-NMR (282.4 MHz, CDCl3) δ −125.8 (s 2F, CF2), −122.3 (s 2F, CF2), −117.7 (s 2F, CF2), −101.8 (s, 2F, CF2-CF2), −80.2 (m 3F, CF3); MS (m/z): 472 ([M − I]+, 90). HRMS calcd. for C17H10ClF11N+: 472.0326, found 472.0324. Anal. Calcd. for C17H10ClF11NI: C, 34.05; H, 1.68; N, 2.34. Found: C, 34.10; H, 1.68; N, 2.35.
2-Perfluoropentyl-6-methyl-N-(2-methoxyphenyl)pyridinium iodide (17k). 6.8 g of 2-methoxyaniline 15k (5.52 × 10−2 mol) and 1.63 mL or 1.28 g (2.21 × 10−2 mol) of acetone 16t were added to a solution of 9.8 g (1.84 × 10−2 mol) of 14 (RF = C5F11) in 98 mL of dry dichloromethane. The mixture was stirred for 6 h at reflux. 7.67 g of the title product 17k were obtained, total yield 70%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 2.8 (s, 3H, CH3), 3.7 (s, 3H, OCH3), 7.1 (d, J = 8.3 Hz, 1H), 7.2 (t, J = 7.6 Hz, 1H), 7.7 (t, J = 8.8 Hz, 1H), 8 (m, 1H), 8.3 (d, J = 8.1 Hz, 1H), 8.8 (d, J = 8.2 Hz, 1H), 9 (d, J = 8.2 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 22.2 (s, CH3), 54 (s, OCH3), 113.1, 128.5, 129.1, 130.8, 133.7, 136.2, 139.9 (t, 2JCF = 25 Hz), 147, 160, 162.2; 19F-NMR (282.4 MHz, CDCl3) δ −126.5 (AB system, 2JFF = 295 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.5 (AB system, 2JFF = 295 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −122.9 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.5 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −119 (AB system, 2JFF = 288 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −116.5 (AB system, 2JFF = 288 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −107 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −99.5 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.69 (m 3F, CF3). MS (m/z): 468 ([M − I]+, 100). HRMS calcd. for C18H13F11NO+: 468.0821, found 468.0827. Anal. Calcd. for C18H13F11INO: C, 36.32; H, 2.20; N, 2.35. Found: C, 36.35; H, 2.21; N, 2.34.
2-Perfluoropentyl-6-methyl-N-(4-methoxyphenyl)pyridinium iodide (17l). 6.94 g of 4-methoxyaniline 15l (5.63 × 10−2 mol) and 1.66 mL or 1.3 g (2.25 × 10−2 mol) of acetone 16t were added to a solution of 10 g (1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9.62 g of the title product 17l were obtained, total yield 86%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 2.7 (s, 3H, CH3), 3.9 (s, 3H, OCH3), 7.2 (d, J = 8.5 Hz, 2H), 7.7 (d, J = 8.4 Hz, 2H), 8.4 (d, J = 7.5 Hz, 1H), 8.8 (d, J = 7.8 Hz, 1H), 9.1 (t, J = 7.8 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 22.3 (s, CH3), 54.2 (s, OCH3), 113, 128.7 (t, 3JCF = 2 Hz), 129.4, 130.5, 133, 136.1, 140 (t, 2JCF = 25 Hz), 147, 160.2, 162.5; 19F-NMR (282.4 MHz, CDCl3) δ −126.1 (s 2F, CF2), −122.3 (s 2F, CF2), −117.1 (s 2F, CF2), −101.8 (s, 2F, CF2-CF2), −80.7 (m 3F, CF3). MS (m/z): 468 ([M − I]+, 100). HRMS calcd. for C18H13F11NO+: 468.0821, found 468.0830. Anal. Calcd. for C18H13F11INO: C, 36.32; H, 2.20; N, 2.35. Found: C, 36.39; H, 2.21; N, 2.38.
2-Perfluoropentyl-N-(phenyl)-5,6,7,8-tetrahydroquinolinium iodide (18a). 5.24 g of aniline 15a (5.63 × 10−2 mole) and 2.21 g (2.25 × 10−2 mole) of cyclohexanone 16u were added to a solution of 10 g (1.87 × 10−2 mole) of 14 (RF = C5F11) in 50 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 10 g of the title product 18a were obtained, total yield 88%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 2 (m, 4H), 2.7 (m, 2H), 3.3 (m, 2H), 7.5–7.6 (m, 3H), 7.7 (d, J = 7.1 Hz, 2H), 8.2 (d, J = 8.1 Hz, 1H), 8.7 (d, J = 8.2 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.5, 21, 29.5, 31.2, 115, 125.1, 127, 128.1, 129.2, 139 (t, 2JCF = 27 Hz), 146, 148.1, 163.1; 19F-NMR (235.3 MHz, CDCl3) δ −126.2 (m 2F, CF2), −122.4 (m 2F, CF2), −117.3 (m 2F, CF2), −101.8 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 478 ([M − I]+, 95). HRMS calcd. for C20H15F11N+ 478.1029, found 478.1033. Anal. Calcd. for C20H15F11NI: C, 39.69; H, 2.50; N, 2.31. Found: C, 39.72; H, 2.51; N, 2.29.
2-Trifluoromethyl-N-(phenyl)-5,6,7,8-tetrahydroquinolinium iodide (18a’). 7.14 g of aniline 15a (7.68 × 10−2 mol) and 3 g (3.07 × 10−2 mol) of cyclohexanone 16u were added to a solution of 8.5 g (2.56 × 10−2 mol) of 14’ (RF = CF3) in 85 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9.23 g of the title product 18a’ were obtained, total yield 89%. 1H-NMR (300.13 MHz, CDCl3) δ 1.9 (m, 4H, CH2, cyclohexyl group), 2.6 (m, 2H, CH2, cyclohexyl group), 3.3 (m, 2H, CH2, cyclohexyl group), 7.5–7.6 (m, 3H, Ph-H), 7.8 (d, J = 7.5 Hz, 2H, Ph-H), 8.2 (d, J = 8 Hz, 1H, Py-H), 8.8 (d, J = 8.1 Hz, 1H, Py-H); 13C-NMR (75.46 MHz, CDCl3) δ 19.8, 21, 29.6, 32.2, 115, 118.6 (q, CF3, 1JCF = 282.5 Hz), 125.2, 127.1, 128.8, 129.2, 139.5, 146.4, 148.5 (q, C-CF3, 2JCF = 34.5 Hz), 163; 19F-NMR (282.4 MHz, DMSO-d6) δ −59.8 (s 3F, CF3). MS (m/z): 278 ([M − I]+, 95). HRMS calcd. for C16H15F3N+: 278.1157, found 278.1160. Anal. Calcd. for C16H15F3NI: C, 47.43; H, 3.73; N, 3.46. Found: C, 47.45; H, 3.74; N, 3.44.
2-Perfluoropentyl-N-(2-methylphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18b). 5.86 g of 2-methylaniline 15b (5.46 × 10−2 mol) and 2.14 g (2.18 × 10−2 mol) of cyclohexanone 16u were added to a solution of 9.7 g (1.82 × 10−2 mol) of 14 (RF = C5F11) in 97 mL of dry dichloromethane. The mixture was stirred for 6 h at reflux. 8.12 g of the title product 18b were obtained, total yield 72%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.8 (bs, 2H), 1.9 (s, 3H, CH3), 2.1 (m, 3H), 2.9 (m, 1H), 3.3 (m, 1H), 3.4 (m, 1H), 7.3–7.5 (m, 3 H), 8 (t, J = 7.2 Hz, 1H), 8.2 (d, J = 8.1 Hz, 1H), 8.8 (d, J = 8.1 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.9, 21, 26, 29.5, 32.1, 115.2, 126.5, 127.8, 128, 129.5, 136.5, 138 (t, 2JCF = 24.2 Hz), 148.1, 150.5, 161.1, 163; 19F-NMR (282.4 MHz, DMSO-d6) δ −126.3 (AB system, 2JFF = 285.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.4 (AB system, 2JFF = 285.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −123.1 (AB system, 2JFF = 310 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.7 (AB system, 2JFF = 310 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −118.7 (AB system, 2JFF = 299.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −117.6 (AB system, 2JFF = 299.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −107.1 (AB system, 2JFF = 290.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −98.2 (AB system, 2JFF = 290.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.2 (m 3F, CF3). MS (m/z): 492 ([M − I]+, 100). HRMS calcd. for C21H17F11N+: 492.1185, found 492.1190. Anal. Calcd. for C21H17F11NI: C, 40.73; H, 2.77; N, 2.26. Found: C, 40.75; H, 2.76; N, 2.25.
2-Perfluoropentyl-N-(3-methylphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18c). 6.4 g of 3-methylaniline 15c (5.97 × 10−2 mol) and 2.34 g (2.39 × 10−2 mol) of cyclohexanone 16u were added to a solution of 10.6 g (1.99 × 10−2 mol) of 14 (RF = C5F11) in 53 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 10.2 g of the title product 18c were obtained, total yield 83%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 2H), 2.1 (s, 3H, CH3), 2.9 (m, 2H), 3.5 (m, 2H), 7.5 (s, 1H), 7.6 (m, 3H), 8.2 (d, J = 8.1 Hz, 1H), 8.7 (d, J = 8.1 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.8, 21.1, 26.3, 29.5, 31, 117.2, 126.1, 127.8, 128.1, 129.2, 136.8, 138.5 (t, 2JCF = 25.8 Hz), 148.2, 150.5, 163.1; 19F-NMR (235.3 MHz, CDCl3) δ −126.1 (m 2F, CF2), −122 (m 2F, CF2), −117 (m 2F, CF2), −103.1 (AB system, 2JFF = 275.6 Hz, 1F, CF2-CF2), −101.2 (AB system, 2JFF = 275.6 Hz, 1F, CF2-CF2), −80.1 (m 3F, CF3). MS (m/z): 492 ([M − I]+, 100). HRMS calcd. for C21H17F11N+: 492.1185, found 492.1187. Anal. Calcd. for C21H17F11NI: C, 40.73; H, 2.77; N, 2.26. Found: C, 40.76; H, 2.77; N, 2.27.
2-Perfluoropentyl-N-(4-methylphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18d). 5.74 g of 4-methylaniline 15d (5.35 × 10−2 mol) and 2.1 g (2.14 × 10−2 mol) of cyclohexanone 16u were added to a solution of 9.5 g (1.78 × 10−2 mol) of 14 (RF = C5F11) in 95 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 8.84 g of the title product 18d were obtained, total yield 80%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.9 (m, 4H), 2 (s, 3H, CH3), 2.5 (m, 2H), 3.4 (m, 2H), 7.4 (d, J = 8 Hz, 2H), 7.7 (d, J = 8.1 Hz, 2H), 8.2 (d, J = 8.1 Hz, 1H), 8.7 (d, J = 8.1 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.5, 21, 26.2, 29.5, 31.2, 116.2, 125.1, 127, 128.1, 129.2, 135.1, 137.8 (t, 2JCF = 26 Hz), 146, 148.1, 150, 163.1; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.5 (m 2F, CF2), −117.5 (m 2F, CF2), −101.2 (m 2F, CF2), −80.6 (m 3F, CF3). MS (m/z): 492 ([M − I]+, 100). HRMS calcd. for C21H17F11N+: 492.1185, found 492.1189. Anal. Calcd. for C21H17F11NI: C, 40.73; H, 2.77; N, 2.26. Found: C, 40.75; H, 2.78; N, 2.25.
2-Perfluoropentyl-N-(4-ethylphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18g). 7.24 g of 4-ethylaniline 15g (5.97 × 10−2 mol) and 2.34 g (2.39 × 10−2 mol) of cyclohexanone 16u were added to a solution of 10.6 g (1.99 × 10−2 mol) of 14 (RF = C5F11) in 106 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 10.72 g of the title product 18g were obtained, total yield 85%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 1.9 (m, 4H), 2.6 (m, 2H), 2.8 (q, J = 8 Hz, 2H, CH2-CH3), 3.3 (m, 2H), 7.1 (d, J = 8.2 Hz, 2H), 7.7 (d, J = 8.3 Hz, 2H), 8.2 (d, J = 8.1 Hz, 1H), 8.6 (d, J = 8.1 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 13.1, 19.5, 21, 24.1, 29.5, 31.2, 113.2, 126.1, 127, 129.6, 129.8, 135.1, 138.8 (t, 2JCF = 26.2 Hz), 148.1, 152, 162.9; 19F-NMR (235.3 MHz, CDCl3) δ −126.9 (m 2F, CF2), −123.5 (m 2F, CF2), −117.5 (m 2F, CF2), −101.8 (m 2F, CF2), −80.6 (m 3F, CF3). MS (m/z): 506 ([M − I]+, 95). HRMS calcd. for C22H19F11N+: 506.1342, found 506.1346. Anal. Calcd. for C22H19F11NI: C, 41.72; H, 3.02; N, 2.21. Found: C, 41.75; H, 3.04; N, 2.19.
2-Perfluoropentyl-N-(3-chlorophenyl)-5,6,7,8-tetrahydroquinolinium iodide (18i). 7.33 g of 3-chloroaniline 15i (5.75 × 10−2 mol) and 2.25 g (2.3 × 10−2 mol) of cyclohexanone 16u were added to a solution of 10.2 g (1.91 × 10−2 mol) of 14 (RF = C5F11) in 102 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9.32 g of the title product 18i were obtained, total yield 76%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 2H), 2.9 (m, 2H), 3.5 (m, 2H), 7.4 (s, 1H), 7.5–7.6 (m, 2H), 7.7 (m, 1H), 8.2 (d, J = 8 Hz, 1H), 8.7 (d, J = 8 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.6, 21, 26, 29.5, 31.5, 118.2, 127.1, 127.8, 128.1, 130.1, 137.8, 138.8 (t, 2JCF = 24.8 Hz), 147.2, 150.6, 165.6; 19F-NMR (235.3 MHz, CDCl3) δ −125.6 (m 2F, CF2), −117.6 (m 2F, CF2), −113.5 (m 2F, CF2), −97.9 (AB system, 2JFF = 150.2 Hz, 1F, CF2-CF2), −98.2 (AB system, 2JFF = 150.2 Hz, 1F, CF2-CF2), −79.1 (m 3F, CF3). MS (m/z): 512 ([M − I]+, 90). HRMS calcd. for C20H14F11NCl+: 512.0639, found 512.0643. Anal. Calcd. for C20H14F11NICl: C, 37.55; H, 2.21; N, 2.19. Found: C, 37.58; H, 2.22; N, 2.17.
2-Perfluoropentyl-N-(4-methoxyphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18l). 7.36 g of 4-anisidine 15l (5.97 × 10−2 mol) and 2.34 g (2.39 × 10−2 mol) of cyclohexanone 16u were added to a solution of 10.6 g (1.99 × 10−2 mol) of 14 (RF = C5F11) in 106 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 11.39 g of the title product 18l were obtained, total yield 90%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 2 (m, 4H), 2.7 (m, 2H), 3.3 (m, 2H), 3.9 (s, 3H, OCH3), 7.1 (d, J = 8.8 Hz, 2H), 7.7 (d, J = 8.6 Hz, 2H), 8.2 (d, J = 8.1 Hz, 1H), 8.8 (d, J = 8.2 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 20.1, 22, 29, 31.1, 56, 117, 125, 127, 128.2, 129.9, 139.5 (t, 2JCF = 27.2 Hz), 146.2, 148.1, 162, 164.5; 19F-NMR (235.3 MHz, CDCl3) δ −126.9 (m 2F, CF2), −123.5 (m 2F, CF2), −117.5 (m 2F, CF2), −101.7 (m 2F, CF2), −80.75 (m 3F, CF3). MS (m/z): 508 ([M − I]+, 100). HRMS calcd. for C21H17F11NO+: 508.1134, found 508.1138. Anal. Calcd. for C21H17F11NIO: C, 39.70; H, 2.70; N, 2.20. Found: C, 39.72; H, 2.71; N, 2.19.
2-Perfluoropentyl-N-(phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19a). 5.24 g of aniline 15a (5.63 × 10−2 mole) and 2.52 g (2.25 × 10−2 mole) of cycloheptanone 16v were added to a solution of 10 g (1.87 × 10−2 mole) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9.54 g of the title product 19a were obtained, total yield 82%. 1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H, CH2, cycloheptyl group), 1.9 (m, 4H, CH2, cycloheptyl group), 3.1 (m, 2H, CH2, cycloheptyl group), 3.4 (m, 2H, CH2, cycloheptyl group), 7.5–7.7 (m, 5H, Ph-H), 8.2 (d, J = 8.2 Hz, 1H, Py-H), 8.9 (d, J = 8 Hz, 1H, Py-H); 13C-NMR (75.46MHz, CDCl3) δ 24, 25.3, 30.7, 33.9, 35.4, 124.2, 125.9, 127.7, 129.6, 131.5, 137.7 (t, 2JCF = 27.1 Hz), 146.8, 150.3, 167.4; 19F-NMR (282.4 MHz, CDCl3) δ −126 (m 2F, CF2-CF2 CF2 CF2-CF3), −122.4 (m 2F, CF2-CF2-CF2-CF2-CF3), −117.3 (m 2F, CF2-CF2-CF2-CF2-CF3), −101.6 (m 2F, CF2-CF2-CF2-CF2-CF3), −80.7 (m 3F, CF2-CF2-CF2 CF2-CF3). MS (m/z): 492 ([M − I]+, 95). HRMS calcd. for C21H17F11N+ 492.1185, found 492.1190. Anal. Calcd. for C21H17F11NI: C, 40.73; H, 2.77; N, 2.26. Found: C, 40.75; H, 2.78; N, 2.25.
2-Perfluoropentyl-N-(3-methylphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19c). 5.92 g of 3-methylaniline 15c (5.52 × 10−2 mol) and 2.47 g (2.21 × 10−2 mol) of cycloheptanone 16v were added to a solution of 9.8 g (1.84 × 10−2 mol) of 14 (RF = C5F11) in 98 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9.68 g of the title product 19c were obtained, total yield 83%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 4H), 2.45 (s, 3H, CH3), 3 (d, J = 8 Hz, 2H), 3.4 (m, 2H), 7.4 (m, 2H), 7.6 (m, 2H), 8.2 (d, J = 8.4 Hz, 1H), 8.9 (d, J = 8 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 20.7, 21.5, 24.3, 25.3, 30.7, 33.9, 35.7, 122.5, 126.2, 127.7, 129.5, 131, 137.6 (t, 2JCF = 27 Hz), 146.6, 150.2, 167.8; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.5 (m 2F, CF2), −117 (m 2F, CF2), −101.7 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 506 ([M − I]+, 95). HRMS calcd. for C22H19F11N+: 506.1342, found 506.1346. Anal. Calcd. for C22H19F11NI: C, 41.72; H, 3.02; N, 2.21. Found: C, 41.75; H, 3.06; N, 2.19.
2-Perfluoropentyl-N-(4-methylphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19d). 6.34 g of 4-methylaniline 15d (5.92 × 10−2 mol) and 2.65 g (2.36 × 10−2 mol) of cycloheptanone 16v were added to a solution of 10.5 g (1.97 × 10−2 mol) of 14 (RF = C5F11) in 105 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 10.62 g of the title product 19d were obtained, total yield 85%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.6 (m, 2H), 1.9 (m, 4H), 2.4 (s, 3H, CH3), 3 (m, 2H), 3.3 (m, 2H), 7.3 (d, J = 8 Hz, 2H), 7.6 (d, J = 8 Hz, 2H), 8.2 (d, J = 8.4 Hz, 1H), 8.8 (d, J = 8.4 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 20.8, 21.3, 24.2, 25.3, 30.6, 33.9, 35.4, 122.7, 126.6, 127.7, 129.9, 130.2, 135.1, 137.8 (t, 2JCF = 27.1 Hz), 142.5, 146.6, 150.2, 167.7; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.4 (m 2F, CF2), −117.2 (m 2F, CF2), −101.6 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 506 ([M − I]+, 95). HRMS calcd. for C22H19F11N+: 506.1342, found 506.1348. Anal. Calcd. for C22H19F11NI: C, 41.72; H, 3.02; N, 2.21. Found: C, 41.76; H, 3.05; N, 2.23.
2-Perfluoropentyl-N-(3-ethylphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19f). 6.69 g of 3-ethylaniline 15f (5.52 × 10−2 mol) and 2.47 g (2.21 × 10−2 mol) of cycloheptanone 16v were added to a solution of 9.8 g (1.84 × 10−2 mol) of 14 (RF = C5F11) in 98 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 10.5 g of the title product 19f were obtained, total yield 88%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.2 (t, J = 8 Hz, 3H, CH2-CH3), 1.6 (s, 2H), 1.9 (m, 4H), 2.7 (q, J = 8 Hz, 2H, CH2-CH3), 3 (m, 2H), 3.3 (m, 2H), 7.5 (m, 3 H), 7.6 (m, 1H), 8.2 (d, J = 8.4 Hz, 1H), 8.9 (d, J = 8 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 15.1, 24.3, 25.4, 28.4, 30.6, 33.9, 35.4, 124.1, 125.9, 127.7, 129.6, 131.5, 137.6 (t, 2JCF = 26.7 Hz), 146.7, 150.2, 167.4; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.4 (m 2F, CF2), −117.2 (m 2F, CF2), −102.2 (AB system, 2JFF = 263.3 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −101.1 (AB system, 2JFF = 263.3 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.7 (m 3F, CF3). MS (m/z): 520 ([M − I]+, 100). HRMS calcd. for C23H21F11N+: 520.1498, found 520.1501. Anal. Calcd. for C23H21F11NI: C, 42.68; H, 3.27; N, 2.16. Found: C, 42.70; H, 3.28; N, 2.14.
2-Perfluoropentyl-N-(4-ethylphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19g). 6.96 g of 4-ethylaniline 15g (5.75 × 10−2 mol) and 2.58 g (2.3 × 10−2 mol) of cycloheptanone 16v were added to a solution of 10.2 g (1.91 × 10−2 mol) of 14 (RF = C5F11) in 102 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 10.3 g of the title product 19g were obtained, total yield 83%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.3 (t, J = 7.6 Hz, 3H, CH2-CH3), 1.6 (s, 2H), 1.8 (m, 4H), 2.71 (q, J = 7.6 Hz, 2H, CH2-CH3), 3 (m, 2H), 3.4 (m, 2H), 7.3 (d, J = 8.4 Hz, 2H), 7.6 (d, J = 8.4 Hz, 2H), 8.1 (d, J = 8 Hz, 1H), 8.8 (d, J = 8 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 14.9, 24.2, 25.3, 28.5, 30.6, 33.9, 35.4, 126.7, 127.7, 128.9, 135.2, 137.8 (t, 2JCF = 27.1 Hz), 146.6, 148.6, 150.2, 167.7; 19F-NMR (235.3 MHz, CDCl3) δ −126.1 (m 2F, CF2), −122.5 (m 2F, CF2), −117.2 (m 2F, CF2), −101.6 (m 2F, CF2), −80.8 (m 3F, CF3). MS (m/z): 520 ([M − I]+, 100). HRMS calcd. for C23H21F11N+: 520.1498, found 520.1499. Anal. Calcd. for C23H21F11NI: C, 42.68; H, 3.27; N, 2.16. Found: C, 42.69; H, 3.29; N, 2.15.
2-Perfluoropentyl-N-(3-chlorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19i). 6.4 g of 3-chloroaniline 15i (5.01 × 10−2 mol) and 2.25 g (2.10−2 mol) of cycloheptanone 16v were added to a solution of 8.9 g (1.67 × 10−2 mol) of 14 (RF = C5F11) in 89 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 7.65 g of the title product 19i were obtained, total yield 70%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.6–2.2 (m, 6H), 3.1 (m, 2H), 3.4 (s, 2H), 7.6 (t, J = 8.1 Hz, 1H), 7.7 (d, J = 8.2 Hz, 1H), 7.9 (s, 1H), 8.1 (d, J = 7.9 Hz, 1H), 8.3 (d, J = 8.1 Hz, 1H), 8.9 (d, J = 8.2 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 24.1, 25.2, 30.7, 34, 34.3, 35.5, 127.9, 128.5, 129.8, 136.1, 137.7 (t, 2JCF = 26.8 Hz), 138.5, 146.8, 150.5, 167.7; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.4 (m 2F, CF2), −117.2 (m 2F, CF2), −101.5 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 526 ([M − I]+, 100). HRMS calcd. for C21H16F11NCl+: 526.0796, found 526.0799. Anal. Calcd. for C21H16F11NICl: C, 38.58; H, 2.47; N, 2.14. Found: C, 38.61; H, 2.48; N, 2.14.
2-Perfluoropentyl-N-(4-chlorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19j). 7.26 g of 4-chloroaniline 15j (5.69 × 10−2 mol) and 2.55 g (2.27 × 10−2 mol) of cycloheptanone 16v were added to a solution of 10.1 g (1.89 × 10−2 mol) of 14 (RF = C5F11) in 101 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9.68 g of the title product 19j were obtained, total yield 78%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 4H), 3 (m, 2H), 3.3 (m, 2H), 7.5 (d, J = 8.8 Hz, 2H), 7.8 (d, J = 8.8 Hz, 2H), 8.2 (d, J = 8 Hz, 1H), 8.8 (d, J = 8.3 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 24, 25.2, 30.7, 33.9, 34.2, 35.4, 127.9, 128.4, 129.9, 136.1, 137.5 (t, 2JCF = 26.8 Hz), 138.3, 146.8, 150.5, 167.6; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.3 (m 2F, CF2), −117.3 (m 2F, CF2), −101.5 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 526 ([M − I]+, 100). HRMS calcd. for C21H16F11NCl+: 526.0796, found 526.0797. Anal. Calcd. for C21H16F11NICl: C, 38.58; H, 2.47; N, 2.14. Found: C, 38.60; H, 2.47; N, 2.13.
2-Perfluoropentyl-N-(2-methoxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19k). 6.18 g of 2-anisidine 15k (5.01 × 10−2 mol) and 2.25 g (2 × 10−2 mol) of cycloheptanone 16v were added to a solution of 8.9 g (1.67 × 10−2 mol) of 14 (RF = C5F11) in 45 mL of dry dichloromethane. The mixture was stirred for 6 h at reflux. 7.6 g of the title product 19k were obtained, total yield 70%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.5 (m, 1H), 1.7–2 (m, 4H), 2.1 (m, 1H), 2.9 (m,1H), 3.2–3.5 (m, 3H), 3.8 (s, 3H, OCH3), 7.2 (d, J = 8.3 Hz, 1H), 7.3 (t, J = 7.6 Hz, 1H), 7.7 (t, J = 8.8 Hz, 1H), 8 (s, 1H), 8.3 (d, J = 8.1 Hz, 1H), 9 (d, J = 8.2 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 24, 25.1, 30.7, 34.4, 34.3, 35.6, 127.8, 128.5, 130, 136.1, 137.8 (t, 2JCF = 26.9 Hz), 138.8, 147, 151.5, 167.5; 19F-NMR (282.4 MHz, DMSO-d6) δ −126.5 (AB system, 2JFF = 284.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.5 (AB system, 2JFF = 284.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −123 (AB system, 2JFF = 355.2 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.8 (AB system, 2JFF = 355.2 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −119.1 (AB system, 2JFF = 380.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −116.5 (AB system, 2JFF = 380.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −107.1 (AB system, 2JFF = 350 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −99.5 (AB system, 2JFF = 350 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.69 (m 3F, CF3). MS (m/z): 522 ([M − I]+, 100). HRMS calcd. for C22H19F11NO+: 522.1291, found 522.1297. Anal. Calcd. for C22H19F11NIO: C, 40.70; H, 2.95; N, 2.16. Found: C, 40.73; H, 2.96; N, 2.16.
2-Perfluoropentyl-N-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19l). 6.66 g of 4-anisidine 15l (5.41 × 10−2 mol) and 2.42 g (2.16 × 10−2 mol) of cycloheptanone 16v were added to a solution of 9.6 g (1.8 × 10−2 mol) of 14 (RF = C5F11) in 96 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 10.31 g of the title product 19l were obtained, total yield 88%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 4H), 3 (m, 2H), 3.3 (m, 2H), 3.8 (s, 3H, OCH3), 7 (d, J = 8.8 Hz, 2H), 7.6 (d, J = 8.4 Hz, 2H), 8.1 (d, J = 8.4 Hz, 1H), 8.7 (d, J = 8 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 24.3, 25.3, 30.7, 33.9, 35.5, 55.8, 114.6, 127.6, 128.2, 130, 138.2, 146.5, 150.2, 161.7, 168.2; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.3 (m 2F, CF2), −117.2 (m 2F, CF2), −101.5 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 522 ([M − I]+, 100). HRMS calcd. for C22H19F11NO+: 522.1291, found 522.1295. Anal. Calcd. for C22H19F11NIO: C, 40.70; H, 2.95; N, 2.16. Found: C, 40.74; H, 2.95; N, 2.13.

3.3. General Procedure for the Synthesis of 2-Trifluoromethylated and 2-Perfluoroalkylated 6-Methyl-N-(o-/p-Carboxyphenyl)Pyridinium Iodides (17m–n’), N-(O-/P-Carboxyphenyl)-5,6,7,8-Tetrahydroquinolinium Iodides (18m–n) and N-(O-Carboxyphenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[b]Pyridinium Iodide (19m)

To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 or 14’ (1 equiv.) in anhydrous dichloromethane (5 mL DCM for 1 g of 1414’), was added three equiv. of the corresponding aminobenzoic acid 15mn and 1.2 equiv. of ketone 16tv. The mixture was stirred under reflux for 12 h (Table 1, Table 2 and Table 3) until complete consumption of 1414’ (monitored by TLC eluent petroleum ether/ethyl acetate: 80/20 v/v, and 19F-NMR of aliquots). When the reaction was completed, the mixture was allowed to cool to r.t. then the brown precipitate accumulated during the reaction was separated by vacuum filtration (it was subsequently identified as anilinium salts by NMR and MS). Then a mixture of petroleum ether and ethyl ether (40/60 v/v) was added to the filtrate and the corresponding pyridinium iodides 17m–n’, 18m–n and 19m instantly precipitate and were isolated by vacuum filtration as amorphous solids.
2-Perfluoropentyl-6-methyl-N-(2-carboxyphenyl)pyridinium iodide (17m). 7.34 g of 2-aminobenzoic acid 15m (5.35 × 10−2 mole) and 1.58 mL or 1.24 g (2.14 × 10−2 mole) of acetone 16t were added to a solution of 9.5 g (1.78 × 10−2 mole) of 14 (RF = C5F11) in 48 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 5.43 g of the title product 17m were obtained, total yield 50%. 1H-NMR (300.13 MHz, DMSO-d6) δ 2.4 (s, 3H, CH3), 7.7–7.9 (m, 3 H), 8.2 (d, J = 8 Hz, 1H), 8.7 (m, 2H), 9 (t, J = 8 Hz, 1H), 13.9 (bs, 1H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6) δ 22.9 (s, CH3), 127.9, 128.6, 129.4, 132.8, 133.6, 134.4, 137, 139.7 (t, 2JCF = 25.1 Hz), 148.2, 163.4, 165.1 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6) δ −126.7 (AB system, 2JFF = 288.7 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.7 (AB system, 2JFF = 288.7 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −122.8 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.8 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −119.2 (AB system, 2JFF = 310.2 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −116.3 (AB system, 2JFF = 310.2 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −107.5 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −99.1 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.69 (m 3F, CF3). MS (m/z): 482 ([M − I]+, 100). HRMS calcd. for C18H11F11NO2+ 482.0614, found 482.0622. Anal. Calcd. for C18H11F11INO2: C, 35.49; H, 1.82; N, 2.30. Found: C, 35.51; H, 1.82; N, 2.33.
2-Trifluoromethyl-6-methyl-N-(2-carboxyphenyl)pyridinium iodide (17m’). 11.02 g of 2-aminobenzoic acid 15m (8.04 × 10−2 mol) and 2.37 mL or 1.86 g (3.21 × 10−2 mol) of acetone 16t were added to a solution of 8.9 g (2.68 × 10−2 mol) of 14’ (RF = CF3) in 89 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 5.7 g of the title product 17m’ were obtained, total yield 52%. Spectral data: 1H-NMR (300.13 MHz, DMSO-d6) δ 2.3 (s, 3H, CH3), 7.7–7.8 (m, 3 H), 8 (d, J = 8.1 Hz, 1H), 8.8 (m, 2H), 9 (t, J = 8 Hz, 1H), 14.2 (bs, 1H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6) δ 21.9 (s, CH3), 118.5 (q, CF3, 1JCF = 280.2 Hz), 127.5 (q, 3JCF = 3.9 Hz), 128, 133.7, 140.2, 140.7, 146, 148.1 (q, C-CF3, 2JCF = 36.6 Hz), 163, 167 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6) δ −60.3 (s 3F, CF3). MS (m/z): 282 ([M − I]+, 100). HRMS calcd. for C14H11F3NO2+: 282.0742, found 282.0745. Anal. Calcd. for C14H11F3INO2: C, 41.10; H, 2.71; N, 3.42. Found: C, 41.13; H, 2.72; N, 3.40.
2-Perfluoropentyl-6-methyl-N-(4-carboxyphenyl)pyridinium iodide (17n). 8.27 g of 4-aminobenzoic acid 15n (6.03 × 10−2 mol) and 1.78 mL or 1.39 g (2.41 × 10−2 mol) of acetone 16t were added to a solution of 10.7 g (2.01 × 10−2 mol) of 14 (RF = C5F11) in 107 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 7.35 g of the title product 17n were obtained, total yield 60%. 1H-NMR (300.13 MHz, DMSO-d6) δ 2.5 (s, 3H, CH3), 8 (d, J = 8.1 Hz, 2H, Ph-H), 8.3 (d, J = 8.1 Hz, 2H, Ph-H), 8.8 (m, 2H, Py-H), 9 (t, J = 8 Hz, 1H, Py-H), 13.8 (bs, 1H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6) δ 22.9 (s, CH3), 127.1, 128.7, 130.5, 133.8, 139.7, 140.7, 146, 147.6, 163.1, 165.9 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6) δ −125.8 (s 2F, CF2-CF2-CF2-CF2-CF3), −122.3 (s 2F, CF2-CF2-CF2-CF2-CF3), −117.7 (s 2F, CF2-CF2-CF2-CF2-CF3), −101.8 (s, 2F, CF2-CF2-CF2-CF2-CF3), −80.2 (m 3F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 482 ([M − I]+, 100). HRMS calcd. for C18H11F11NO2+: 482.0614, found 482.0620. Anal. Calcd. for C18H11F11INO2: C, 35.49; H, 1.82; N, 2.30. Found: C, 35.52; H, 1.83; N, 2.28.
2-Trifluoromethyl-6-methyl-N-(4-carboxyphenyl)pyridinium iodide (17n’).12.63 g of 4-aminobenzoic acid 15n (9.21 × 10−2 mol) and 2.72 mL or 2.13 g (3.68 × 10−2 mol) of acetone 16t were added to a solution of 10.2 g (3.07 × 10−2 mol) of 14’ (RF = CF3) in 102 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 7.54 g of the title product 17n’ were obtained, total yield 60%. Spectral data: 1H-NMR (300.13 MHz, DMSO-d6) δ 2.5 (s, 3H, CH3), 8.1 (d, J = 8 Hz, 2H), 8.3 (d, J = 8 Hz, 2H), 8.7 (m, 2H), 9.1 (t, J = 8 Hz, 1H), 14 (bs, 1H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6) δ 22.7 (s, CH3), 118 (q, CF3, 1JCF = 279 Hz), 127.1 (q, 3JCF = 4.2 Hz), 128, 130.4, 133.7, 140, 140.7, 146, 147.6 (q, C-CF3, 2JCF = 35.5 Hz), 163, 166 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6) δ −59.9 (s 3F, CF3). MS (m/z): 282 ([M − I]+, 100). HRMS calcd. for C14H11F3NO2+: 282.0742, found 282.0747. Anal. Calcd. for C14H11F3INO2: C, 41.10; H, 2.71; N, 3.42. Found: C, 41.14; H, 2.70; N, 3.40.
2-Perfluoropentyl-N-(2-carboxyphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18m). 7.88 g of 2-aminobenzoic acid 15m (5.75 × 10−2 mol) and 2.25 g (2.3 × 10−2 mole) of cyclohexanone 16u were added to a solution of 10.2 g (1.91 × 10−2 mol) of 14 (RF = C5F11) in 51 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 8.96 g of the title product 18m were obtained, total yield 72%. 1H-NMR (300.13 MHz, CDCl3) δ 1.8 (s, 2H, CH2, cyclohexyl group), 2 (s, 2H, CH2, cyclohexyl group), 2.4 (m, 1H, CH2, cyclohexyl group), 2.7 (m, 1H, CH2, cyclohexyl group), 3.1 (m, 1H, CH2, cyclohexyl group), 3.3 (m, 1H, CH2, cyclohexyl group), 6.9 (bs, 1H, CO2H), 7.8 (m, 3H, Ph-H), 8.2 (d, J = 7.4 Hz, 1H, Ph-H), 8.4 (d, J = 8.1 Hz, 1H, Py-H), 8.9 (d, J = 8.2 Hz, 1H, Py-H); 1H-NMR (400.13 MHz, DMSO-d6) δ 1.6–1.8 (m, 4H, CH2, cyclohexyl group), 2.3 (m, 1H, CH2, cyclohexyl group), 2.6 (m, 1H, CH2, cyclohexyl group), 3.2 (m, 2H, CH2, cyclohexyl group), 7.8–8 (m, 3H, Ph-H), 8.3 (d, J = 8 Hz, 1H, Ph-H), 8.6 (d, J = 8 Hz, 1H, Py-H), 8.9 (d, J = 8 Hz, 1H, Py-H); 13C-NMR (75.46 MHz, CDCl3) δ 19.9, 21.4, 29.5, 30.5, 126.5, 126.7, 130.6, 132.2, 132.7, 133.2, 136.4, 139.3 (t, 2JCF = 25 Hz), 144.4, 147.5, 161.6, 165.8 (s, CO2H); 13C-NMR (100.6 MHz, DMSO-d6) δ 20, 21.4, 29.1, 30.3, 127.2 (t, 3JCF = 4 Hz, =C-H, Py), 128.5, 132.6, 133, 134.6, 136.6, 137.2, 137.4 (t, 2JCF = 22.13 Hz, =C-CF2, Py), 144.7, 148, 162.2, 164.9 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6) δ −126.5 (AB system, 2JFF = 282 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.3 (AB system, 2JFF = 282 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −123 (AB system, 2JFF = 367 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.9 (AB system, 2JFF = 367 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −118.9 (AB system, 2JFF = 338 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −117 (AB system, 2JFF = 338 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −107 (AB system, 2JFF = 310 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −98.5 (AB system, 2JFF = 310 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.31 (m 3F, CF3). MS (m/z): 522 ([M − I]+, 98). HRMS calcd. for C21H15F11NO2+ 522.0927, found 522.0933. Anal. Calcd. for C21H15F11NIO2: C, 38.85; H, 2.33; N, 2.16. Found: C, 38.88; H, 2.34; N, 2.15.
2-Perfluoropentyl-N-(4-carboxyphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18n). 8.27 g of 4-aminobenzoic acid 15n (6.03 × 10−2 mol) and 2.36 g (2.41 × 10−2 mol) of cyclohexanone 16u were added to a solution of 10.7 g (2.01 × 10−2 mol) of 14 (RF = C5F11) in 53.5 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 9.14 g of the title product 18n were obtained, total yield 70%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 2 (m, 4H), 2.6 (m, 2H), 3.4 (m, 2H), 7.9 (d, J = 8 Hz, 2H), 8.2 (d, J = 8 Hz, 2H), 8.8 (d, J = 8.1 Hz, 1H), 9 (d, J = 8.1 Hz, 1H) 12.9 (bs, 1H, CO2H); 13C-NMR (75.46MHz, CDCl3) δ 20.8, 21, 29.2, 31.5, 125.5, 127, 128.4, 129.5, 133.7, 139.7 (t, 2JCF = 24.3 Hz), 146, 147.2, 163.1, 166 (s, CO2H); 19F-NMR (235.3 MHz, CDCl3) δ −125.9 (m 2F, CF2), −122.5 (m 2F, CF2), −117.7 (m 2F, CF2), −101.5 (m 2F, CF2), −80.4 (m 3F, CF3). MS (m/z): 522 ([M − I]+, 90). HRMS calcd. for C21H15F11NO2+: 522.0927, found 522.0931. Anal. Calcd. for C21H15F11NIO2: C, 38.85; H, 2.33; N, 2.16. Found: C, 38.89; H, 2.34; N, 2.15.
2-Perfluoropentyl-N-(2-carboxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19m). 8.35 g of 2-aminobenzoic acid 15m (6.09 × 10−2 mol) and 2.73 g (2.43 × 10−2 mole) of cycloheptanone 16v were added to a solution of 10.8 g (2.03 × 10−2 mole) of 14 (RF = C5F11) in 54 mL of dry dichloromethane. The mixture was stirred for 6 h at reflux. 9.15 g of the title product 19m were obtained, total yield 68%. 1H-NMR (300.13 MHz, CDCl3) δ 1.4–2 (m, 6H, CH2, cycloheptyl group), 2.7 (m, 1H, CH2, cycloheptyl group), 3 (m, 1H, CH2, cycloheptyl group), 3.3–3.4 (m, 2H, CH2, cycloheptyl group), 7.7 (bs, 1H, CO2H), 7.77 (m, 3H, Ar-H), 8.1 (d, J = 8 Hz, 1H, Ar-H), 8.3 (d, J = 8 Hz, 1H, Py-H), 8.9 (d, J = 8 Hz, 1H, Py-H); 1H-NMR (300.13 MHz, DMSO-d6) δ 1.4 (m, 1H, CH2, cycloheptyl group), 1.6–1.9 (m, 5H, CH2, cycloheptyl group), 2.8 (m, 2H, CH2, cycloheptyl group), 3.3 (m, 2H, CH2, cycloheptyl group), 7.9 (m, 2H, Ar-H), 8 (m, 1H, Ar-H), 8.4 (d, J = 6 Hz, 1H, Ar-H), 8.6 (d, J = 6.15 Hz, 1H, Py-H), 8.9 (d, J = 6.18 Hz, 1H, Py-H); 13C-NMR (75.46MHz, DMSO-d6) δ 24, 25.5, 30.4, 33.4, 35.3, 127.2, 127.5, 129.7, 132.2, 132.6, 132.9, 137.1, 138.2 (t, 2JCF = 20.1 Hz), 147.1, 149.2, 165.1, 166.6; 19F-NMR (282.4 MHz, DMSO-d6) δ −126.6 (AB system, 2JFF = 293.4 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.5 (AB system, 2JFF = 293.4 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −123.4 (AB system, 2JFF = 297.1 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −122.3 (AB system, 2JFF = 297.1 Hz, 1F, CF2-CF2-CF2-CF2-CF3), -119 (AB system, 2JFF = 300.96 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −116.5 (AB system, 2JFF = 300.96 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −108.2 (AB system, 2JFF = 285.9 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −97.9 (AB system, 2JFF = 285.9 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.86 (m 3F, CF3). MS (m/z): 536 ([M − I]+, 95). HRMS calcd. for C22H17F11NO2+ 536.1084, found 536.1089. Anal. Calcd. for C22H17F11NIO2: C, 39.84; H, 2.58; N, 2.11. Found: C, 39.86; H, 2.59; N, 2.10.

3.4. General Procedure for the Synthesis 2-Trifluoromethyl or 2-Perfluoroalkyl-7-Methoxyquinolines 20o–o’

To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 or 14’ (1 equiv.) in anhydrous dichloromethane (10 mL DCM for 1g of 1414’), was added 3 equiv. of meta-anisidine 15o. The mixture was stirred under reflux for the desired time (12 h, Table 4) until complete consumption of 1414’ (monitored by TLC eluent petroleum ether/ethyl acetate: 80/20 v/v, and 19F-NMR of aliquots). When the reaction was completed, the mixture was concentrated under reduced pressure and then stirred with diethyl ether. An excess of petroleum ether was added; the precipitate that had formed was eliminated by vacuum filtration and washed three times with petroleum ether. The filtrate was concentrated in vacuo to give a brown oil. Chromatography over silica gel column (eluent, petroleum ether/ethyl acetate 98/2 v/v) left a yellow oil which was crystallized from methanol/water to give pure samples of the corresponding quinolines 20oo’.

3.5. General Procedure for the Synthesis 2-Trifluoromethyl or 2-Perfluoroalkyl-7-Methoxyquinolines 20oo’ in the Presence of Ketones 16tv

To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 or 14’ (1 equiv.) in anhydrous dichloromethane (10 mL DCM for 1 g of 1414’), was added three equiv. of meta-anisidine 15o and 1.2 equiv. of ketone 16tv. The mixture was stirred under reflux for desired time (12 h, Table 4) until complete consumption of 1414’ (monitored by TLC eluent petroleum ether/ethyl acetate: 80/20 v/v, and 19F-NMR of aliquots). When the reaction was completed, the mixture was concentrated under reduced pressure and then stirred with a mixture of petroleum ether/ethyl acetate. Chromatography over silica gel column (eluent, petroleum ether/ethyl acetate 98/2 v/v) left a yellow oil which was crystallized from methanol/water to give pure samples of the corresponding quinolines 20oo’. We were able to isolate unreacted ketones 16tv from the corresponding reactions (1.2 equivalent) which were identified and characterized by NMR and mass spectroscopy
2-perfluoropentyl-6-methoxyquinoline (20o). 6.25 g of meta-anisidine 15o (5.07 × 10−2 mol) and 2.03 × 10−2 mole of the corresponding ketone (1.17 g of acetone 16t or 1.99 g of cyclohexanone 16u or 2.27 g of cylcoheptanone 16v) were added to a solution of 9 g (1.69 × 10−2 mole) of 14 (RF = C5F11) in 90 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. In the presence of acetone: 6.1 g of 20o (85% yield) and 0.5 g of 16t. Or in the presence of cyclohexanone: 5.9 g of 20o (82% yield) and 1.9 g of 16u. Or in the case of cycloheptanone: 5.9 g of 20o (82% yield) and 2.25 g of 16u were obtained respectively.
Or 6.8 g of meta-anisidine 15o (5.52 × 10−2 mol) were added to a solution of 9.8 g (1.84 ×10−2 mol) of 14 (RF = C5F11) in 98 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 6.6 g (84% yield) of quinoline 20o were obtained respectively. 1H-NMR (300.13 MHz, CDCl3) δ 3.8 (s, 3H, OCH3), 7.5 (d, J = 8.5 Hz, 1H), 7.8 (d, J = 8.6 Hz, 1H), 8 (m, 2H), 8.6 (d, J = 8.6 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 55.6 (s, OCH3), 117.6, 126.5, 130.5, 130.7, 135.2, 138.7, 139.8, 146.3, 147.8 (t, 2JCF = 26 Hz, C-CF2); 19F-NMR (282.4 MHz, CDCl3) δ −126.5 (m 2F, CF2-CF2-CF2-CF2-CF3), −122.5 (m 2F, CF2-CF2-CF2-CF2-CF3), −122 (m 2F, CF2-CF2-CF2-CF2-CF3), −114.5 (m, 2F, CF2-CF2-CF2-CF2-CF3), −81.2 (m 3F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 428 [M + H]+. HRMS m/z [M + H]+ calcd. for C15H9F11NO+: 428.0508, found: 428.0510. Anal calcd. for C15H8F11NO: C, 42.17; H, 1.89; N, 3.28, found: C, 42.19; H, 1.88; N, 3.26.
2-Trifluoromethyl-6-methoxyquinoline (20o’). 10.9 g of 3-anisidine 15o (8.85 × 10−2 mol) and 2.6 mL or 2 g (3.54 × 10−2 mol) of acetone 16t were added to a solution of 9.8 g (2.95 × 10−2 mol) of 14’ (R’F = C2F5) in 98 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 5.9 g of the quinoline 20o’ were obtained, total yield 88%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 3.8 (s, 3H, OCH3), 7.6 (d, J = 8.4 Hz, 1H), 7.8 (d, J = 8.5 Hz, 1H), 7.9–8 (m, 2H), 8.5 (d, J = 8.5 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 55.5 (s, OCH3), 116.5 (q, 3JCF = 2.1 Hz, CH-C-CF3), 122.8 (q, 1JCF = 275.6 Hz, CF3), 128, 128.5, 129.3, 132.1, 136, 139.1, 142.6, 148.5 (q, 2JCF = 34 Hz, C-CF3); 19F-NMR (282.4 MHz, CDCl3) δ − 67.8 (m 3F, CF3). MS (m/z): 228 [M + H]+. HRMS m/z [M + H]+ calcd. for C11H9F3NO+: 228.0636, found: 228.0643. Anal calcd. for C11H8F3NO: C, 58.15; H, 3.55; N, 6.17, found: C, 58.17; H, 3.56; N, 6.15.

3.6. General Procedure for the Preparation and Isolation of 2-Perfluoroalkyl- and 2-Trifluoromethyl-1-(R-phenyl)amino-3-(R-phenyl)iminopropene Intermediates 21al (all examples except R = CO2H or R = m-OMe)

A mixture of one equivalent of gem-iodoacetate compounds 14 or 14’ or 14” and two equivalents of the corresponding anilines 15a–l in dichloromethane (10 mL DCM for 1 g of 1414”) was stirred at room temperature until disappearance of 19F-NMR signals corresponding to the starting products 1414” (2–6 h). At the end of the reaction, a solution of 10% sodium thiosulfate was added to the reaction mixture and the product was extracted three times with ether. The combined extracts were washed several times with aqueous 0.5 M hydrochloric solution, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give a bright yellow oil. Chromatography over silica gel column (eluent: petroleum ether/ethyl acetate 98/2 v/v) yielded the pure compounds 21al as yellow liquids.
3-Perfluoropenthyl-1-phenylamino-3-phenyliminopropene (21a). 3.49 g of aniline 15a (3.75 × 10−2 mol) were added to a solution of 10 g (1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 8.28 g of the title product 21a were obtained, total yield 90%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21a) δ 5.5 (d, 3JHH = 13 Hz, 1H, CH=CH-NH), 6.8 (t (AB system), J = 8.7 Hz, 4Hortho, Ph-H), 6.9 (t, J = 7.4 Hz, 1Hpara, Ph-H), 7.1 (t, J = 7.4 Hz, 1Hpara, Ph-H), 7.2 (t, J = 8.1 Hz, 2Hmeta, Ph-H), 7.4 (t, J = 7.8 Hz, 2Hmeta, Ph-H), 7.45 (m, 1H, CH=CH-NH), 9.9 (d, 3JHNH = 12.8 Hz, CH=CH-NH); 1H-NMR (300.13 MHz, DMSO-d6/D2O, EEE-21a) δ 5.4 (d, 3JHH = 13 Hz, 1H, CH=CH-NH), 6.7 (d, J = 8.5 Hz, 4Hortho, Ph-H), 6.9 (t, J = 7.5 Hz, 1Hpara, Ph-H), 7.1 (t, J = 7.4 Hz, 1Hpara, Ph-H), 7.2 (t, J = 8 Hz, 2Hmeta, Ph-H), 7.4 (t, J = 8 Hz, 2Hmeta, Ph-H), 7.45 (m, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21a) δ 91.5, 114.6, 118.5, 122.1, 123.5, 129.1, 129.5, 130, 140.5, 141.5 (t, 3JCF = 5.4 Hz, CF2-(C=N)-CH=CH-NH), 149.9, 153.6 (t, 2JC1F = 22.5 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21a) δ −80.2 (t, J = 8.4 Hz, 3F, CF2-CF2-CF2-CF2-CF3), −109.5 (t, J = 11 Hz, 2F, CF2-CF2-CF2-CF2-CF3), −120.4 (m, 2F, CF2-CF2-CF2-CF2-CF3), −121 (q, J = 5.6 Hz, 2F, CF2-CF2-CF2-CF2-CF3), −125.8 (t, J = 11.2 Hz, 2F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 491 [M + H]+. HRMS calcd. for C20H14F11N2+: 491.0981, found: 491.0985; Anal calcd. for C20H13F11N2: C, 48.99; H, 2.67; N, 5.71, found C, 48.97; H, 2.66; N, 5.74.
3-Trifluoromethyl-1-phenylamino-3-phenyliminopropene (21a’). 3.64 g of aniline 15a (3.91 × 10−2 mol) were added to a solution of 6.5 g (1.95 × 10−2 mol) of 14’ (RF = CF3) in 65 mL of dry dichloromethane. The mixture was stirred for 3 h at room temperature. 4.65 g of the title product 21a’ were obtained, total yield 82%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21a’) δ 5.5 (d, J = 13.7 Hz, 1H, CH=CH-NH), 6.8 (d, J = 7.5 Hz, 2H), 7 (m, 3H), 7.15 (t, J = 7.4 Hz, 1H), 7.3 (t, J = 7.8 Hz, 2H), 7.4 (t, J = 7.7 Hz, 2H), 7.6 (t, J = 13 Hz, 1H, CH=CH-NH), 9.9 (d, J = 12.3 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21a’) δ 90.8, 115.1, 119.4, 120.5 (q, CF3, 1JCF = 279.2 Hz), 122.2, 123.5, 129.1, 129.5, 140.64, 140.8 (q, 3JCF = 3 Hz, CF3-(C=N)-CH=CH-NH), 149.5, 153.3 (q, 2JCF = 30.5 Hz, CF3-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21a’) δ −65.7 (s, 3F). MS (m/z): 291 [M + H]+. HRMS calcd. for C16H14F3N2+: 291.1109, found 291.1110. Anal. Calcd. for C16H13F3N2: C, 66.20; H, 4.51; N, 9.65. Found: C, 66.19; H, 4.48; N, 9.55.
3-perfluoropropyl-1-phenylamino-3-phenyliminopropene (21a”). 2.36 g of aniline 15a (2.54 × 10−2 mol) were added to a solution of 5.5 g (1.27 × 10−2 mol) of 14” (RF = C3F7) in 55 mL of dry dichloromethane. The mixture was stirred for 3 h at room temperature. 4.22 g of the title product 21a” were obtained, total yield 85%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21a”) δ 5.5 (d, J = 13.5 Hz, 1H, CH=CH-NH), 6.8 (d, J = 7.4 Hz, 2H), 7 (m, 3H), 7.2 (t, J = 7.4 Hz, 1H), 7.3 (t, J = 7.7 Hz, 2H), 7.4 (t, J = 7.7 Hz, 2H), 7.7 (t, J = 13.1 Hz, 1H, CH=CH-NH), 9.9 (d, J = 12.1 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21a’’) δ 90.5, 115, 118.5, 122, 123.5, 129.3, 129.7, 130, 140.5, 141 (t, 3JCF = 5 Hz, CF2-(C=N)-CH=CH-NH), 150, 153.6 (t, 2JCF = 21.5 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21a”) δ −80.5 (m, 3F), −109.1 (t, J = 11 Hz, 2F), −126 (m, 2F). MS (m/z): 391 [M + H]+. HRMS calcd. for C18H14F7N2+: 391.1045, found: 391.1055; Anal calcd. for C18H13F7N2: C, 55.39; H, 3.36; N, 7.18, found C, 55.41; H, 3.35; N, 7.15.
3-perfluoropentyl-1-(2-methylphenylamino)-3-(2-methylphenylimino)-propene (21b). 3.26 g of 2-methylaniline 15b (3.04 × 10−2 mol) were added to a solution of 8.1 g (1.52 × 10−2 mol) of 14 (RF = C5F11) in 81 mL of dry dichloromethane. The mixture was stirred for 6 h at room temperature. 5.52 g of the title product 21b were obtained, total yield 70%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21b) δ 2.1 (s, 3H), 2.3 (s, 3H), 5.6 (d, J = 13.1 Hz, CH=CH-NH), 6.5–7.3 (m, 8H, HAr), 7.6 (m, 1H, CH=CH-NH), 9.3 (bs, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21b) δ 18.8, 18.9, 89, 113.1, 117.7, 121.5, 123.5, 129, 129.3, 130, 140.5, 141.5 (t, 3JCF = 4.8 Hz, CF2-(C=N)-CH=CH-NH), 150.1, 153.5 (t, 2JC1F = 20.5 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21b) δ −80.5 (m, 3F), −109 (m, 2F), −120.5 (m, 2F), −121 (m, 2F), −125.5 (m, 2F). MS (m/z): 519 [M + H]+. HRMS calcd. for C22H18F11N2+: 519.1294, found: 519.1298; Anal calcd. for C22H17F11N2: C, 50.97; H, 3.31; N, 5.40, found C, 50.99; H, 3.30; N, 5.37.
3-perfluoropentyl-1-(3-methylphenylamino)-3-(3-methylphenylimino)-propene (21c). 3.22 g of 3-methylaniline 15c (3.10−2 mol) were added to a solution of 8 g (1.5 × 10−2 mol) of 14 (RF = C5F11) in 80 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 6.23 g of the title product 21c were obtained, total yield 80%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21c) δ 2.2 (s, 3H), 2.3 (s, 3H), 5.4 (d, J = 13.6 Hz, 1H, CH=CH-NH), 6.6 (m, 2H), 6.7 (m, 3H), 6.9 (d, J = 7.6 Hz, 1H), 7.1 (m, 1H), 7.2 (t, J = 7.6 Hz, 1H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.7 (d, J = 12.5 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21c) δ 20.5, 20.9, 89, 113.5, 117.5, 121.5, 123.5, 129, 129.5, 130.2, 140, 141.1 (t, 3JCF = 5.3 Hz, CF2-(C=N)-CH=CH-NH), 150, 153 (t, 2JC1F = 21.5 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21c) δ −80.5 (m, 3F), −109.6 (m, 2F), −120.2 (m, 2F), −121.5 (m, 2F), −125.5 (m, 2F). MS (m/z): 519 [M + H]+. HRMS calcd. for C22H18F11N2+: 519.1294, found: 519.1295; Anal calcd. for C22H17F11N2: C, 50.97; H, 3.31; N, 5.40, found C, 50.99; H, 3.28; N, 5.38
3-perfluoropentyl-1-(4-methylphenylamino)-3-(4-methylphenylimino)-propene (21d). 3.62 g of 4-methylaniline 15d (3.38 × 10−2 mol) were added to a solution of 9 g (1.69 × 10−2 mol) of 14 (RF = C5F11) in 90 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7.71 g of the title product 21d were obtained, total yield 88%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21d) δ 2.2 (s, 3H), 2.3 (s, 3H), 5.4 (d, J = 13 Hz, 1H, CH=CH-NH), 6.7 (d, J = 8 Hz, 2H), 6.8 (d, J = 8.2 Hz, 2H), 7.1 (d, J = 8.2 Hz, 2H), 7.2 (d, J = 8 Hz, 2H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.7 (d, J = 12.4 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21d) δ 20.1, 20.4, 90.2, 115.5, 117.5, 122, 124.5, 129.2, 129.5, 140, 141.9 (t, 3JCF = 3.5 Hz, CF2-(C=N)-CH=CH-NH), 150.5, 152.9 (t, 2JC1F = 31.1 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21d) δ −80.3 (m, 3F), −109.5 (m, 2F), −120.1 (m, 2F), −121.5 (m, 2F), −125 (m, 2F). MS (m/z): 519 [M + H]+. HRMS calcd. for C22H18F11N2+: 519.1294, found: 519.1290; Anal calcd. for C22H17F11N2: C, 50.97; H, 3.31; N, 5.40, found C, 50.97; H, 3.29; N, 5.42
3-Trifluoromethyl-1-(4-methylphenylamino)-3-(4-methylphenylimino)-propene (21d’). 5.48 g of 4-methylaniline 15d (5.12 × 10−2 mol) were added to a solution of 8.5 g (2.56 × 10−2 mol) of 14’ (RF = CF3) in 85 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7 g of the title product 21d’ were obtained, total yield 86%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21d’) δ 2.2 (s, 3H), 2.3 (s, 3H), 5.4 (d, J = 13.8 Hz, 1H, CH=CH-NH), 6.7 (d, J = 8 Hz, 2H), 6.8 (d, J = 8.2 Hz, 2H), 7.1 (d, J = 8.2 Hz, 2H), 7.2 (d, J = 8 Hz, 2H), 7.5 (t, J = 12.9 Hz, 1H, CH=CH-NH), 9.7 (d, J = 12.4 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21d’) δ 20.1, 20.3, 90.4, 115, 119.1, 120.6 (q, 1JCF = 279.5 Hz, CF3), 129.1, 129.7, 129.9, 130.8, 131.1, 132.5, 138.2, 140.8 (q, 3JCF = 3.1 Hz, CF3-(C=N)-CH=CH-NH), 147, 153.4 (q, 2JCF = 30.8 Hz, CF3-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21d’) δ −65.7 (s, 3F). MS (m/z): 319 [M + H]+. HRMS calcd. for C18H18F3N2+: 319.1422, found: 319.1425; Anal calcd. for C18H17F3N2: C, 67.91; H, 5.38; N, 8.80, found C, 67.95; H, 5.37; N, 8.82.
3-perfluoropentyl-1-(2-ethylphenylamino)-3-(2-ethylphenylimino)-propene (21e). 3.59 g of 2-ethylaniline 15e (2.96 × 10−2 mol) were added to a solution of 7.9 g (1.48 × 10−2 mol) of 14 (RF = C5F11) in 79 mL of dry dichloromethane. The mixture was stirred for 6 h at room temperature. 5.43 g of the title product 21e were obtained, total yield 67%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21e) δ 1.2 (t, J = 8 Hz, 3H, CH2-CH3), 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.5 (q, J = 8 Hz, 2H, CH2-CH3), 2.7(q, J = 8 Hz, 2H, CH2-CH3), 5.6 (d, J = 12.8 Hz, CH=CH-NH), 6.5–7.3 (m, 8H, HAr), 7.5 (m, 1H, CH=CH-NH), 9.1 (bs, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21e) δ 13.2 (s, CH2-CH3), 13.3 (s, CH2-CH3), 24.1 (s, CH2-CH3), 24.3 (s, CH2-CH3), 89, 112.9, 117.5, 121.2, 129.3, 129.4, 130.5, 140.5, 141 (t, 3JCF = 4.9 Hz, CF2-(C=N)-CH=CH-NH), 149.9, 153.1 (t, 2JC1F = 21.5 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21e) δ −80.6 (m, 3F), −109.2 (m, 2F), −120.1 (m, 2F), −121.1 (m, 2F), −125 (m, 2F). MS (m/z): 547 [M + H]+. HRMS calcd. for C24H22F11N2+: 547.1607, found: 547.1610; Anal calcd. for C24H21F11N2: C, 52.75; H, 3.87; N, 5.13, found C, 52.76; H, 3.88; N, 5.10.
3-perfluoropentyl-1-(3-ethylphenylamino)-3-(3-ethylphenylimino)-propene (21f). 3.87 g of 3-ethylaniline 15f (3.19 × 10−2 mol) were added to a solution of 8.5 g (1.59 × 10−2 mol) of 14 (RF = C5F11) in 85 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 6.71 g of the title product 21f were obtained, total yield 77%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21f) δ 1.1 (t, J = 8 Hz, 3H, CH2-CH3), 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.6 (q, J = 8 Hz, 2H, CH2-CH3), 2.7 (q, J = 8 Hz, 2H, CH2-CH3), 5.4 (d, J = 13.1 Hz, 1H, CH=CH-NH), 6.6–6.8 (m, 5H), 6.9 (d, J = 7.5 Hz, 1H), 7.1 (m, 1H), 7.2 (t, J = 7.6 Hz, 1H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.8 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21f) δ 13.1 (s, CH2-CH3), 13.3 (s, CH2-CH3), 24 (s, CH2-CH3), 24.3 (s, CH2-CH3), 90.2, 114.1, 117.8, 122, 123.1, 129, 129.2, 130.2, 140, 141.1 (t, 3JCF = 5.9 Hz, CF2-(C=N)-CH=CH-NH), 151.1, 153.5 (t, 2JC1F = 22.1 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21f) δ −81.5 (m, 3F), −109.1 (m, 2F), −120.2 (m, 2F), −121.5 (m, 2F), −126.1 (m, 2F). MS (m/z): 547 [M + H]+. HRMS calcd. for C24H22F11N2+: 547.1607, found: 547.1611; Anal calcd. for C24H21F11N2: C, 52.75; H, 3.87; N, 5.13, found C, 52.78; H, 3.88; N, 5.14.
3-perfluoropentyl-1-(4-ethylphenylamino)-3-(4-ethylphenylimino)-propene (21g). 4 g of 4-ethylaniline 15g (3.3 × 10−2 mol) were added to a solution of 8.8 g (1.65 × 10−2 mol) of 14 (RF = C5F11) in 88 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7.67 g of the title product 21g were obtained, total yield 85%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21g) δ 1.2 (t, J = 8 Hz, 3H, CH2-CH3), 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.6 (q, J = 8 Hz, 2H, CH2-CH3), 2.7 (q, J = 8 Hz, 2H, CH2-CH3), 5.6 (d, J = 13.4 Hz, 1H, CH=CH-NH), 6.6 (d, J = 8.1 Hz, 2H), 6.8 (d, J = 8.2 Hz, 2H), 7.1 (d, J = 8.2 Hz, 2H), 7.2 (d, J = 8.1 Hz, 2H), 7.5 (t, J = 12.8 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.7 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21g) δ 13.3 (s, CH2-CH3), 13.4 (s, CH2-CH3), 24.3 (s, CH2-CH3), 24.5 (s, CH2-CH3), 90.2, 115.5, 117.5, 123.1, 125.2, 129.1, 129.3, 140.5, 141.9 (t, 3JCF = 4.2 Hz, CF2-(C=N)-CH=CH-NH), 151.5, 153.4 (t, 2JC1F = 32.2 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21g) δ −80.7 (m, 3F), −109.5 (m, 2F), −120.7 (m, 2F), −122.4 (m, 2F), −125.8 (m, 2F). MS (m/z): 547 [M + H]+. HRMS calcd. for C24H22F11N2+: 547.1607, found: 547.1609; Anal calcd. for C24H21F11N2: C, 52.75; H, 3.87; N, 5.13, found C, 52.77; H, 3.87; N, 5.14.
3-Trifluoromethyl-1-(4-ethylphenylamino)-3-(4-ethylphenylimino)-propene (21g’). 6.56 g of 4-ethylaniline 15g (5.42 × 10−2 mol) were added to a solution of 9 g (2.71 × 10−2 mol) of 14’ (RF = CF3) in 90 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7.97 g of the title product 21g’ were obtained, total yield 85%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21g’) δ 1.2 (t, J = 7.8 Hz, 3H, CH2-CH3), 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.5 (q, J = 7.9 Hz, 2H, CH2-CH3), 2.7 (q, J = 8.1 Hz, 2H, CH2-CH3), 5.5 (d, J = 13.6 Hz, 1H, CH=CH-NH), 6.7 (d, J = 7.9 Hz, 2H), 6.8 (d, J = 8 Hz, 2H), 7.1 (d, J = 8.1 Hz, 2H), 7.2 (d, J = 8 Hz, 2H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.4 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21g’) δ 13.3 (s, CH2-CH3), 13.4 (s, CH2-CH3), 24.3 (s, CH2-CH3), 24.5 (s, CH2-CH3), 90.6, 116.2, 120.1, 120.5 (q, 1JCF = 280.5 Hz, CF3), 129.7, 129.9, 130.8, 131, 132.5, 138.3, 140.8 (q, 3JCF = 4.2 Hz, CF3-(C=N)-CH=CH-NH), 147.5, 153.1 (q, 2JCF = 29.9 Hz, CF3-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21g’) δ −65.5 (s, 3F). MS (m/z): 347 [M + H]+. HRMS calcd. for C20H22F3N2+: 347.1735, found: 347.1740; Anal calcd. for C20H21F3N2: C, 69.35; H, 6.11; N, 8.09, found C, 69.41; H, 6.10; N, 8.11.
3-perfluoropentyl-1-(2-chlorophenylamino)-3-(2-chlorophenylimino)-propene (21h). 4.84 g of 2-chloroaniline 15h (3.79 × 10−2 mol) were added to a solution of 10.1 g (1.89 × 10−2 mol) of 14 (RF = C5F11) in 101 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 6.57 g of the title product 21h were obtained, total yield 62%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21h) δ 5.6 (d, J = 13.8 Hz, 1H, CH=CH-NH), 6.9 (d, J = 7.71 Hz, 1HAr), 7.1–7.4 (m, 7HAr), 7.5 (d, J = 7.9 Hz, 1H, CH=CH-NH), 9.5 (bs, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21h) δ 90.1, 114.2, 115.1, 117.1, 121.2, 129.3, 129.4, 130.5, 140.5, 149.9, 153.2 (t, 2JC1F = 29.8 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21h) δ −80.6 (m, 3F), −109.5 (m, 2F), −120.3 (m, 2F), −121.1 (m, 2F), −125 (m, 2F). MS (m/z): 560 [M + H]+. HRMS calcd. for C20H12Cl2F11N2+: 559.0202, found: 559.0210; Anal calcd. for C20H11Cl2F11N2: C, 42.96; H, 1.98; N, 5.01, found C, 42.95; H, 1.96; N, 5.10.
3-perfluoropentyl-1-(3-chlorophenylamino)-3-(3-chlorophenylimino)-propene (21i). 4.79 g of 3-chloroaniline 15i (3.75 × 10−2 mol) were added to a solution of 10 g (1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7.35 g of the title product 21i were obtained, total yield 70%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21i) δ 5.6 (d, J = 13.6 Hz, 1H, CH=CH-NH), 6.7–6.9 (m, 6H), 7.2–7.3 (m, 2H), 7.5 (t, J = 13.2 Hz, 1H, CH=CH-NH), 9.7 (d, J = 12.8 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21i) δ 90.4, 112.2, 115.1, 116.4, 117.1, 121.4, 129.1, 129.5, 130.6, 141.5, 150.2, 153.2 (t, 2JC1F = 30.2 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21i) δ −80.5 (m, 3F), −109.1 (m, 2F), −120.1 (m, 2F), −121.1 (m, 2F), −125 (m, 2F). MS (m/z): 560 [M + H]+. HRMS calcd. for C20H12Cl2F11N2+: 559.0202, found: 559.0205; Anal calcd. for C20H11Cl2F11N2: C, 42.96; H, 1.98; N, 5.01, found C, 42.98; H, 1.97; N, 5.00.
3-perfluoropentyl-1-(4-chlorophenylamino)-3-(4-chlorophenylimino)-propene (21j). 4.6 g of 4-chloroaniline 15j (3.6 × 10−2 mol) were added to a solution of 9.6 g (1.8 × 10−2 mol) of 14 (RF = C5F11) in 96 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7.76 g of the title product 21j were obtained, total yield 77%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21j) δ 5.4 (d, J = 13.6 Hz, 1H, CH=CH-NH), 6.8 (d, J = 8 Hz, 2H), 7 (d, J = 8.1 Hz, 2H), 7.3 (d, J = 8.2 Hz, 2H), 7.4 (d, J = 8 Hz, 2H), 7.6 (t, J = 13.2 Hz, 1H, CH=CH-NH), 9.8 (d, J = 12.9 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21j) δ 90.3, 116.1, 117.5, 123, 125.2, 129.2, 129.3, 140.6, 141.5 (t, 3JCF = 5.1 Hz, CF2-(C=N)-CH=CH-NH), 151.6, 153.5 (t, 2JC1F = 31.1 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21j) δ −80.6 (m, 3F), −109.2 (m, 2F), −120.5 (m, 2F), −122.5 (m, 2F), −125.2 (m, 2F). MS (m/z): 560 [M + H]+. HRMS calcd. for C20H12Cl2F11N2+: 559.0202, found: 559.0209; Anal calcd. for C20H11Cl2F11N2: C, 42.96; H, 1.98; N, 5.01, found C, 42.99; H, 1.98; N, 5.03.
3-perfluoropentyl-1-(2-methoxyphenylamino)-3-(2-methoxyphenylimino)-propene (21k). 3.93 g of 2-methoxyaniline 15k (3.19 × 10−2 mol) were added to a solution of 8.5 g (1.59 × 10−2 mol) of 14 (RF = C5F11) in 85 mL of dry dichloromethane. The mixture was stirred for 6 h at room temperature. 5.97 g of the title product 21k were obtained, total yield 68%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21k) δ 3.7 (s, 3H, OCH3), 3.8 (s, 3H, OCH3), 5.5 (d, J = 12.8 Hz, CH=CH-NH), 6.5–7.4 (m, 8H, HAr), 7.5 (m, 1H, CH=CH-NH), 9.1 (bs, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21k) δ 55.5 (s, OCH3), 55.6 (s, OCH3), 89.2, 112.5, 116.9, 120.8, 129.1, 129.2, 130.2, 132.1, 140.6, 141.2 (t, 3JCF = 4.5 Hz, CF2-(C=N)-CH=CH-NH), 149.2, 152.9 (t, 2JC1F = 20.1 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21k) δ −80.6 (m, 3F), −109.1 (m, 2F), −120.1 (m, 2F), −121.3 (m, 2F), −125.5 (m, 2F). MS (m/z): 551 [M + H]+. HRMS calcd. for C22H18F11N2O2+: 551.1193, found: 551.1199; Anal calcd. for C22H17F11N2O2: C, 48.01; H, 3.11; N, 5.09, found C, 48.08; H, 3.10; N, 5.11.
3-perfluoropentyl-1-(4-methoxyphenylamino)-3-(4-methoxyphenylimino)-propene (21l). 4.25 g of 4-anisidine 15l (3.45 × 10−2 mol) were added to a solution of 9.2 g (1.72 × 10−2 mol) of 14 (RF = C5F11) in 92 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 6.84 g of the title product 21l were obtained, total yield 72%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21l) δ 3.7 (s, 3H, OCH3), 3.8 (s, 3H, OCH3), 5.6 (d, J = 13.1 Hz, 1H, CH=CH-NH), 6.6 (d, J = 7.9 Hz, 2H), 6.8 (d, J = 8 Hz, 2H), 7.1 (d, J = 8 Hz, 2H), 7.2 (d, J = 8.1 Hz, 2H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.4 (d, J = 12.7 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21l) δ 55.5 (s, OCH3), 55.7 (s, OCH3), 89.8, 114.8, 115.6, 117.52, 123.1, 125, 129, 129.3, 139.8, 141.5 (t, 3JCF = 3.9 Hz, CF2-(C=N)-CH=CH-NH), 151.1, 154.2 (t, 2JC1F = 29.6 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21l) δ −80.5 (m, 3F), −109 (m, 2F), −120.3 (m, 2F), −122.2 (m, 2F), −125.5 (m, 2F). MS (m/z): 551 [M + H]+. HRMS calcd. for C22H18F11N2O2+: 551.1193, found: 551.1195; Anal calcd. for C22H17F11N2O2: C, 48.01; H, 3.11; N, 5.09, found C, 48.05; H, 3.12; N, 5.08.

3.7. General Procedure for the Isolation of 2-Perfluoropentyl- and 2-Trifluoromethyl-1-((2-/4-)-Carboxy-phenyl)Amino-3-((2-/4-)-Carboxyphenyl)Iminopropene Intermediates 21mn’

A mixture of one equivalent of gem-iodoacetate compounds 14 or 14’ and two equivalents of the corresponding aminobenzoic acid 15m–n in dichloromethane (10 mL DCM for 1 g of 1414’) was stirred at reflux until disappearance of 19F-NMR signals corresponding to the starting products 1414’ (2–4 h). The reaction mixture was concentrated in vacuo and then diluted with diethyl ether. An excess of petroleum ether was added, and the precipitate that had formed was eliminated by vacuum filtration. The filtrate was concentrated under reduced pressure to give brown oil. Chromatography over silica gel column (eluent, petroleum ether/ethyl acetate 90/10 v/v) then purification over a plate chromatography (eluent petroleum ether/ethyl acetate 70/30 v/v) yielded pure compounds 21m-n’ as yellow amorphous solids.
3-perfluoropentyl-1-(2-carboxyphenylamino)-3-(2-carboxyphenylimino)-propene (21m). 5.15 g of 2-aminobenzoic acid 15m (3.75 × 10−2 mol) were added to a solution of 10 g (1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 4.88 g of the title product 21m were obtained after column chromatography, yield 45%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21m) δ 5.7 (d, 3JHH = 13.7 Hz, CH=CH-NH), 6.9–7.45 (m, 8H, HAr), 7.6 (m, 1H, CH=CH-NH), 9.6 (bs, 1H, CH=CH-NH), 14 (bs, 2H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21m) δ 90.1, 114.5, 115, 118.1, 120.8, 129.1, 129.4, 131.2, 141.5, 150.5, 153.1 (t, 2JC1F = 25.6 Hz, CF2-(C=N)-CH=CH-NH), 170.5 (s, CO2H), 170.7 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21m) δ −80.3 (m, 3F), −109.68 (m, 2F), −120.4 (m, 2F), −121.05 (m, 2F), −125.83 (m, 2F). MS (m/z): 579 [M + H]+. HRMS calcd. for C22H14F11N2O4+: 579.0778, found: 579.0783 Anal calcd. for: C22H13F11N2O4: C, 45.69; H, 2.27; N, 4.84, found C, 45.72; H, 2.26; N,4.82.
3-Trifluoromethyl-1-(2-carboxyphenylamino)-3-(2-carboxyphenylimino)-propene (21m’). 6.44 g of 2-aminobenzoic acid 15m (4.69 × 10−2 mol) were added to a solution of 7.8 g (2.34 × 10−2 mol) of 14’ (RF = CF3) in 78 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 3.99 g of the title product 21m’ were obtained after column chromatography, yield 45%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21m’) δ 5.7 (d, J = 13.6 Hz, CH=CH-NH), 6.8–7.5 (m, 8H, HAr), 7.6 (m, 1H, CH=CH-NH), 9.7 (bs, 1H, CH=CH-NH), 14.1 (bs, 2H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21m’) δ 91.4, 115.2, 119.5, 121 (q, 1JCF = 277.7 Hz, CF3), 129.2, 129.7, 130.1, 130.8, 131.5, 132.5, 138.1, 140.7 (q, 3JCF = 2.8 Hz, CF3-(C=N)-CH=CH-NH), 147.1, 153.5 (q, 2JCF = 30.1 Hz, CF3-(C=N)-CH=CH-NH), 170.3 (s, CO2H), 170.5 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21m’) δ −65.6 (s, 3F). MS (m/z): 379 [M + H]+. HRMS calcd. for C18H14F3N2O4+: 379.0906, found: 379.0911 Anal calcd. for: C18H13F3N2O4: C, 57.15; H, 3.46; N, 7.41, found C, 57.19; H, 3.45; N,7.40.
3-Perfluoropenthyl-1-(4-carboxyphenyl)amino-3-(4-carboxyphenyl)iminopropene (21n). 5.15 g of 4-aminobenzoic acid (3.75 × 10−2 mole) were added to a solution of 10 g (1.87 × 10−2 mole) of 14 (R’F = C6F13) in 100 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 5.21 g of the title product 21n were obtained after column chromatography, yield 48%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21n) δ 5.4 (d, 3JHH = 12.9 Hz, 1H, CH=CH-NH), 6.8 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 7.3 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 7.4 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.6 (t (dd), 3JHH = 3JHNH = 12.5 Hz, 1H, CH=CH-NH), 9.9 (d, 3JHNH = 12.2 Hz, CH=CH-NH), 13.5 (bs, 2H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21n) δ 91, 115.5, 118.5, 121.9, 123.5, 129.2, 129.5, 130.1, 142.5, 141.9 (t, 3JCF = 4.9 Hz, CF2-(C=N)-CH=CH-NH), 149.8, 153.8 (t, 2JC1F = 20.5 Hz, CF2-(C=N)-CH=CH-NH); 170.1 (s, CO2H), 170.4 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21n) δ −80.5 (m, 3F, CF2-CF2-CF2-CF2-CF3), −109.2 (t, J = 11.2 Hz, 2F, CF2-CF2-CF2-CF2-CF3), −120.4 (m, 2F, CF2-CF2-CF2-CF2-CF3), −121.5 (m, 2F, CF2-CF2-CF2-CF2-CF3), −125.5 (m, 2F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 579 [M + H]+. HRMS calcd. for C22H14F11N2O4+: 579.0778, found: 579.0782 Anal calcd. for: C22H13F11N2O4: C, 45.69; H, 2.27; N, 4.84, found C, 45.71; H, 2.26; N,4.82.
3-Trifluoromethyl-1-(4-carboxyphenylamino)-3-(4-carboxyphenylimino)-propene (21n’). 8.67 g of 4-aminobenzoic acid 15n (6.32 × 10−2 mol) were added to a solution of 10.5 g (3.16 × 10−2 mol) of 14 (RF = CF3) in 105 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 6.57 g of the title product 21n’ were obtained after column chromatography, yield 55%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21n’) δ 5.5 (d, 3JHH = 13 Hz, 1H, CH=CH-NH), 6.8 (d, J = 8 Hz, 2H), 7.1 (d, J = 8.1 Hz, 2H), 7.3 (d, J = 8 Hz, 2H), 7.4 (d, J = 8.1 Hz, 2H), 7.6 (t, J = J = 12.8 Hz, 1H, CH=CH-NH), 9.8 (d, J = 12.5 Hz, CH=CH-NH), 13.8 (bs, 2H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21n’) δ 91.1, 115.5, 119.8, 121.5 (q, CF3, 1JCF = 278.2 Hz), 123.1, 123.5, 128.9, 129.2, 140.5, 141.2 (q, 3JCF = 2.1 Hz, CF3-(C=N)-CH=CH-NH), 150.2, 153.5 (q, 2JCF = 27.5 Hz, CF3-(C=N)-CH=CH-NH), 170 (s, CO2H), 170.2 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21n’) δ −65.5 (s, 3F). MS (m/z): 379 [M + H]+. HRMS calcd. for C18H14F3N2O4+: 379.0906, found: 379.0910 Anal calcd. for: C18H13F3N2O4: C, 57.15; H, 3.46; N, 7.41, found C, 57.19; H, 3.45; N,7.42.

3.8. General Procedure for the Preparation and Isolation of 2-Perfluoropentyl- and 2-Trifluoromethyl-1-(3-Methoxyphenyl)Amino-3-(3-Methoxyphenyl)Iminopropene Intermediates 21oo’

A mixture of one equivalent of gem-iodoacetate compounds 14 or 14’ and two equivalents of 3-anisidine 15o in dichloromethane (20 mL DCM for 1 g of 1414’) was stirred at room temperature. The evolution of the reaction was monitored by TLC (eluent petroleum ether/ethyl acetate: 80/20 v/v), and 19F-NMR spectroscopy of aliquots. After four h of stirring, a solution of 10% sodium thiosulfate was added to the reaction mixture and the product was extracted three times with ether. The combined extracts were washed two times with saturated sodium bicarbonate solution, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give a yellow oil. Chromatography over silica gel column (eluent: petroleum ether/ethyl acetate 98/2 v/v), then purification over a plate chromatography (eluent petroleum ether/ethyl acetate 85/15 v/v) yielded the pure compounds 21oo’ as yellow liquids.
3-Perfluoropenthyl-1-(3-methoxyphenyl)amino-3-(3-methoxyphenyl)iminopropene (21o). 3.98 g of 3-anisidine 15o (3.23 × 10−2 mole) were added to a solution of 8.6 g (1.61 × 10−2 mole) of 14 (RF = C5F11) in 172 mL of dry dichloromethane. 4 g of the title product 21o were obtained after column chromatography, yield 45%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21o) δ 3.7 (s, 3H, OCH3), 3.8 (s, 3H, OCH3), 5.4 (d, J = 13.1 Hz, 1H, CH=CH-NH), 6.6–6.9 (m, 6H, Ph-H), 7.1 (t, J = 7.4 Hz, 1H, Ph-H), 7.3 (t, J = 7.4 Hz, 1H, Ph-H), 7.6 (t, J = 12.9 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.8 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21o) δ 55.5 (s, OCH3), 55.6 (s, OCH3), 89.5, 113.5, 115.5, 117.5, 121.5, 123.5, 129.1, 129.4, 130.6, 140, 140.8 (t, 3JCF = 4.2 Hz, CF2-(C=N)-CH=CH-NH), 150.5, 153.2 (t, 2JC1F = 26.7 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21o) δ −80.5 (m, 3F, CF2-CF2-CF2-CF2-CF3), −109.5 (m, 2F, CF2-CF2-CF2-CF2-CF3), −120.5 (m, 2F, CF2-CF2-CF2-CF2-CF3), −121.3 (m, 2F, CF2-CF2-CF2-CF2-CF3), −125.6 (m, 2F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 551 [M + H]+. HRMS calcd. for C22H18F11N2O2+: 551.1193, found: 551.1198; Anal calcd. for C22H17F11N2O2: C, 48.01; H, 3.11; N, 5.09, found C, 48.03; H, 3.11; N, 5.10.
3-Trifluoromethyl-1-(3-methoxyphenyl)amino-3-(3-methoxyphenyl)iminopropene (21o’). 6.67 g of 3-anisidine 15o (5.42 × 10−2 mol) were added to a solution of 9 g (2.71 × 10−2 mol) of 14’ (RF = CF3) in 180 mL of dry dichloromethane. 4.55 g of the title product 21o’ were obtained after column chromatography, yield 48%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21o’) δ 3.7 (s, 3H, OCH3), 3.8 (s, 3H, OCH3), 5.4 (d, J = 13 Hz, 1H, CH=CH-NH), 6.7–6.9 (m, 6H, Ph-H), 7.1 (t, J = 7.3 Hz, 1H, Ph-H), 7.3 (t, J = 7.4 Hz, 1H, Ph-H), 7.7 (t, J = 12.7 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.6 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21o’) δ 55.5 (s, OCH3), 55.6 (s, OCH3), 90.2, 113.1, 115.5, 116.5, 119.4, 120.7 (q, 1JCF = 278.7 Hz, CF3), 123.5, 124.2, 129.6, 138.7, 139.1, 140.5, 141 (q, 3JCF = 2.8 Hz, CF3-(C=N)-CH=CH-NH), 149.6, 153.5 (q, 2JCF = 30.1 Hz, CF3-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21o’) δ −65.6 (s, 3F, CF3). MS (m/z): 351 [M + H]+. HRMS calcd. for C18H18F3N2O2+: 351.1320, found: 351.1322; Anal calcd. for C18H17F3N2O2: C, 61.71; H, 4.89; N, 8.00, found C, 61.75; H, 4.88; N, 8.01.

3.9. Reaction of N,N’-Diaryl-2-(Perfluoroalkyl)-1,5-Diazapentadienes 21ao’ with Anilines 15ao and Ketones 16tv: Formation of 2-Trifluoromethyl-/2-Perfluoroalkyl-N-Arylpyridinium Derivatives 1719 or 2-Trifluoromethyl-/2-Perfluoroalkyl-7-Methoxyquinolines 20oo’

To a stirred solution of N,N’-diaryl-2-(perfluoroalkyl)-1.5-diazapentadienes 21ao’ (1 equiv.) in anhydrous dichloromethane (10 mL DCM for 1g of 21), was added one equiv. of the corresponding substituted aniline 15ao and 1.2 equiv. of ketone 16tv. The mixture was stirred under reflux for desired time (4–12 h) until complete consumption of 21ao’ (monitored by TLC eluent petroleum ether/ethyl acetate: 80/20 v/v, and 19F-NMR of aliquots). When the reaction was completed, the mixture was allowed to cool to r.t. then the brown precipitate accumulated during the reaction was separated by vacuum filtration (it was subsequently identified as anilinium salts by NMR and MS).
Then in the cases of pyridinium iodides 17al, 18al and 19al, ethyl ether was added to the filtrate. However, in the cases of pyridinium iodides 17mn’, 18mn and 19m, a mixture of petroleum ether and ethyl ether (40/60 v/v) was added to the corresponding filtrates and the expected pyridiniums 17an’, 18an and 19am precipitate instantly and were isolated by vacuum filtration as amorphous solids.
In the case of 3-anisidine (15o) at the end of the reaction, the mixture was concentrated under reduced pressure and then stirred with diethyl ether. An excess of petroleum ether was added; the precipitate that had formed was eliminated by vacuum filtration and washed three times with petroleum ether. The filtrate was concentrated in vacuo to give a yellow oil. Chromatography over silica gel column (eluent, petroleum ether/ethyl acetate 98/2 v/v) left a yellow oil which was crystallized from methanol/water to give pure samples of the corresponding quinolines 20oo’. All the isolated pyridiniums 17an’, 18an, 19am and quinolines 20oo’ were fully characterized and found identical to the previously obtained products.

4. Conclusions

We have developed a new simple and efficient method for the synthesis of substituted 2-trifluoromethyl-/2-perfluoroalkyl-N-arylpyridiniums 17an’, 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-5,6,7,8-tetrahydroquinoliniums 18an and 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums 19am, starting from perfluoroalkylated gem-iodoacetoxy derivative 1414”, substituted anilines 15ao and ketones 16tv, under mild conditions with good to excellent yields. To our knowledge this is the first synthesis of pyridinium derivatives by a multicomponent reaction involving an activated β-dicarbonyl compound, a ketone, and an aromatic amine.
The reaction is assumed to proceed by a cascade cyclisation mechanism [66,67,68,69,70], either through an inverse electron demand Diels-Alder (IEDDA) cycloaddition, or through an Aza-Robinson cyclisation (Scheme 7), both ways being supported by the isolation and characterization of the intermediate N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapentadiene 21ao’, while stereoelectronic effects may account for the preferred intramolecular diazapentadiene cyclization in the case of the m-methoxy substituent, selectively forming the perfluoroalkylated quinoline 20.
Beyond the scope of this work, various literature reports point out such hetero-Diels-Alder reactions as possibly relevant of bio-orthogonal chemistry because of their selectivity, moderate activation energy and ability to proceed under biological conditions, taking in account e.g., the pH and temperature [66,67,68,69,70]. Besides, since pyridinium-containing compounds are considered as possible exogenous neurotoxins, research efforts have also been undertaken to disclose the formation of such compounds under endogenous (biogenic) conditions [33,34,35,36,37,43,44,45]. In this respect, the biological activity of newly synthesized pyridinium compounds 1719, are currently under evaluation with promising results to be published in future papers.

Supplementary Materials

Supplementary Materials can be accessed.

Author Contributions

S.E.K., P.L. and H.B. designed the researches, S.E.K. and P.L. performed the experiments and physical analyses, S.E.K., P.L. and L.B. analyzed the results and wrote the paper.

Acknowledgments

This work has been supported by the University of Montpellier (formerly the University of Montpellier-2), the CNRS (France), and the Saint Joseph University of Beirut (USJ). We are grateful to Dolla Karam Sarkis, Vice-Rector of USJ, who has been supportive of this work and who worked actively to provide the protected academic time to pursue these researches. We are particularly indebted to Marianne Abi Fadel, Dean of the Faculty of Pharmacy at USJ, for her help and her continuous interest about this work. We want to thank Maryse Béjaud for assistance with the NMR instrumentation and for helpful discussions. Finally, we express our gratitude to emeritus Gérard Lefranc for all his help and support making the collaboration between our laboratories possible.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Madaan, P.; Tyagi, V.K. Quaternary pyridinium salts: A review. J. Oleo Sci. 2008, 57, 197–215. [Google Scholar] [CrossRef] [PubMed]
  2. Anthoni, U.; Christophersen, C.; Hongaard, L.; Nielsen, P.H. Quaternary ammonium compounds in the biosphere—An example of a versatile adaptive strategy. Comp. Biochem. Physiol. 1991, 99, 1–18. [Google Scholar] [CrossRef]
  3. Welton, T. Room-Temperature Ionic Liquids. Solvents for Synthesis and Catalysis. Chem. Rev. 1999, 99, 2071–2083. [Google Scholar] [CrossRef] [PubMed]
  4. Zhou, J.; Hu, Y.; Hu, H. The First Approach to the Synthesis of 1-Unsubstituted 2-Arylindolizines by Intramolecular 1,5-Dipolar Cyclization of 2-(2-Arylethenyl) pyridinium Ylides in the Presence of Tetrakis(pyridine)cobalt (II) Dichromate. Synthesis 1999, 1999, 166–170. [Google Scholar] [CrossRef]
  5. Sowmiah, S.; Esperança, J.M.S.S.; Rebeloac, L.P.N.; Afonso, C.A.M. Pyridinium salts: From synthesis to reactivity and applications. Org. Chem. Front. 2018, 5, 453–493. [Google Scholar] [CrossRef]
  6. Sliwa, W. N-Substituted Salts of Pyridine and Related Compounds, Synthesis, Properties, Applications; Academic Press: Częstochowa, Poland, 1996. [Google Scholar]
  7. Eicher-Lorka, O.; Kupetis, G.K.; Rastenyte, L.; Matijoska, A. A Convenient Preparation of 1-Vinylpyridinium Salts. Synthesis 1999, 1999, 2131–2137. [Google Scholar] [CrossRef]
  8. Scriven, E.F.V. 4-Dialkylaminopyridines: Super acylation and alkylation catalysts. Chem. Soc. Rev. 1983, 12, 129–161. [Google Scholar] [CrossRef]
  9. Dehmlow, E.V.; Dehmlow, S.S. Phase Transfer Catalysis, 3rd ed.; VCH: Weinheim, Germany, 1993. [Google Scholar]
  10. Lavilla, R. Recent developments in the chemistry of dihydropyridines. J. Chem. Soc. Perkin Trans. 1 2002, 9, 1141–1156. [Google Scholar] [CrossRef]
  11. Kuethe, J.T.; Comins, D.L. Asymmetric Total Synthesis of (+)-Cannabisativine. J. Org. Chem. 2004, 69, 5219–5231. [Google Scholar] [CrossRef] [PubMed]
  12. Hayakawa, K.; Shiomi, D.; Ise, T.; Sato, K.; Takui, T. Pyridine-substituted nitronyl nitroxide biradicals: A triplet (S = 1) ground state lasting out N-methylation. J. Mater. Chem. 2006, 16, 4146–4154. [Google Scholar] [CrossRef]
  13. Pernak, J.; Branicka, M. The properties of 1-alkoxymethyl-3-hydroxypyridinium and 1-alkoxymethyl-3-dimethylaminopyridinium chlorides. J. Surfactants Deterg. 2003, 6, 119–123. [Google Scholar] [CrossRef]
  14. Maeda, T.; Manabe, Y.; Yamamoto, M.; Yoshida, M.; Okazaki, K.; Nagamune, H.; Kourai, H. Synthesis and Antimicrobial Characteristics of Novel Biocides, 4, 4’-(1, 6-Hexamethylenedioxydicarbonyl) bis (1-alkylpyridinium iodide) s. Chem. Pharm. Bull. 1999, 47, 1020–1023. [Google Scholar] [CrossRef] [PubMed]
  15. Haldar, J.; Kondaiah, P.; Bhattacharya, S. Synthesis and Antibacterial Properties of Novel Hydrolyzable Cationic Amphiphiles. Incorporation of Multiple Head Groups Leads to Impressive Antibacterial Activity. J. Med. Chem. 2005, 48, 3823–3831. [Google Scholar] [CrossRef] [PubMed]
  16. Thorsteinsson, T.; Masson, M.; Kristinsson, K.G.; Hjalmarsdottir, M.A.; Hilmarsson, H.; Loftsson, T. Soft Antimicrobial Agents: Synthesis and Activity of Labile Environmentally Friendly Long Chain Quaternary Ammonium Compounds. J. Med. Chem. 2003, 46, 4173–4181. [Google Scholar] [CrossRef] [PubMed]
  17. Kourai, H.; Yabuhara, T.; Shirai, A.; Maeda, T.; Hideki Nagamune, H. Syntheses and antimicrobial activities of a series of new bis-quaternary ammonium compounds. Eur. J. Med. Chem. 2006, 41, 437–444. [Google Scholar] [CrossRef] [PubMed]
  18. Schulze, W.; Gutsche, W.; Vater, W.; Oertel, B.; Böhm, K.J.; Unger, E.; Werner, W. Influence of 1,4-benzoquinone derivatives and azomethines on microtubule formation in vitro and experimental leukemias. Pharmazie 1990, 45, 686–687. [Google Scholar] [PubMed]
  19. Calas, M.; Ouattara, M.; Piquet, G.; Ziora, Z.; Bordat, Y.; Ancelin, M.L.; Escale, R.; Vial, H. Potent Antimalarial Activity of 2-Aminopyridinium Salts, Amidines, and Guanidines. J. Med. Chem. 2007, 50, 6307–6315. [Google Scholar] [CrossRef]
  20. Yoshikawa, M.; Motoshima, K.; Fujimoto, K.; Tai, A.; Kakuta, H.; Sasaki, K. Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum. Bioorg. Med. Chem. 2008, 16, 6027–6033. [Google Scholar] [CrossRef]
  21. Scarpini, E.; Scheltens, P.; Feldman, H. Treatment of Alzheimer’s disease: Current status and new perspectives. Lancet Neurol. 2003, 2, 539–547. [Google Scholar] [CrossRef]
  22. Ibach, B.; Haen, E. Acetylcholinesterase inhibition in Alzheimer’s Disease. Curr. Pharm. Des. 2004, 10, 231–251. [Google Scholar] [CrossRef]
  23. Alptüzün, V.; Kapkova, P.; Baumann, K.; Erciyas, E.; Holzgrabe, U. Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors. J. Pharm. Pharmacol. 2003, 55, 1397–1404. [Google Scholar] [CrossRef] [PubMed]
  24. Casey, J.R.; Morgan, P.E.; Vullo, D.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C.T. Carbonic Anhydrase Inhibitors. Design of Selective, Membrane-Impermeant Inhibitors Targeting the Human Tumor-Associated Isozyme IX. J. Med. Chem. 2004, 47, 2337–2347. [Google Scholar] [CrossRef] [PubMed]
  25. Pastorekova, S.; Casini, A.; Scozzafava, A.; Vullo, D.; Pastorek, J.; Supuran, C.T. Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg. Med. Chem. 2004, 14, 869–873. [Google Scholar] [CrossRef] [PubMed]
  26. Springer, D.M.; Luh, B.-Y.; Goodrich, J.T.; Bronson, J.J. Anti-MRSA cephems. Part 3: Additional C-7 acid derivatives. Bioorg. Med. Chem. 2003, 11, 281–291. [Google Scholar] [CrossRef]
  27. Koya, K.; Li, Y.; Wang, H.; Ukai, T.; Tatsuta, N.; Kawakami, M.; Shishido, T.; Chen, L.B. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. Cancer Res. 1996, 56, 538–543. [Google Scholar]
  28. Novgorodov, S.A.; Szule, Z.M.; Luberto, C.; Jones, J.A.; Bielawski, J.; Bielawski, A.; Hannun, Y.A.; Obeid, L.M. Positively charged ceramide is a potent inducer of mitochondrial permeabilization. J. Biol. Chem. 2005, 280, 16096–16105. [Google Scholar] [CrossRef] [PubMed]
  29. Satyal, U.; Draghici, B.; Dragic, L.L.; Zhang, Q.; Norris, K.W.; Madesh, M.; Brailoiu, E.; Ilies, M.A. Interfacially Engineered Pyridinium Pseudogemini Surfactants as Versatile and Efficient Supramolecular Delivery Systems for DNA, siRNA, and mRNA. ACS Appl. Mater. Interfaces 2017, 9, 29481–29495. [Google Scholar] [CrossRef]
  30. Ilies, M.A.; Sommers, T.V.; He, L.C.; Kizewski, A.; Sharma, V.D. Pyridinium Amphiphiles in Gene Delivery—Present and Perspectives in Amphiphiles: Molecular Assembly and Applications Chapter 2. ACS Symp. Ser. 2011, 1070, 23–38. [Google Scholar]
  31. Ilies, M.A.; Satyal, U.; Sharma, V.D. Synthetic Delivery Systems for DNA, siRNA, and mRNA Based on Pyridinium Amphiphiles in Control of Amphiphile Self-Assembling at the Molecular Level: Supra-Molecular Assemblies with Tuned Physicochemical Properties for Delivery Applications, Chapter 1. ACS Symp. Ser. 2017, 1271, 1–34. [Google Scholar]
  32. Sharma, V.D.; Lees, J.; Hoffman, N.E.; Brailoiu, E.; Madesh, M.; Wunder, S.L.; Ilies, M.A. Modulation of Pyridinium Cationic Lipid–DNA Complex Properties by Pyridinium Gemini Surfactants and Its Impact on Lipoplex Transfection Properties. Mol. Pharm. 2014, 11, 545–559. [Google Scholar] [CrossRef]
  33. Williams, A.C.; Cartwright, L.S.; Ramsden, D.B. Parkinson’s disease: The first common neurological disease due to auto-intoxication? Qjm 2005, 98, 215–226. [Google Scholar] [CrossRef] [PubMed]
  34. Langston, J.W.; Forno, L.S.; Tetrud, J.; Reeves, A.G.; Kaplan, J.A.; Karluk, D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 1999, 46, 598–605. [Google Scholar] [CrossRef]
  35. Dauer, W.; Przedborski, S. Parkinson’s disease: Mechanisms and models. Neuron 2003, 39, 889–909. [Google Scholar] [CrossRef]
  36. Javitch, J.A.; D’Amato, R.J.; Strittmatter, S.M.; Snyder, S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 1985, 82, 2173–2177. [Google Scholar] [CrossRef] [PubMed]
  37. Laurencé, C.; Rivard, M.; Lachaise, I.; Bensemhoun, J.; Martens, T. Preparative access to transformation products (TPs) of furosemide: A versatile application of anodic oxidation. Tetrahedron 2011, 67, 9518–9521. [Google Scholar] [CrossRef]
  38. Di Llio, C.; Sacchetta, P.; Iannarelli, V.; Aceto, A. Binding of pesticides to alpha, mu and pi class glutathione transferase. Toxicol. Lett. 1995, 76, 173–177. [Google Scholar] [CrossRef]
  39. Barbeau, A.; Roy, M.; Bernier, G.; Campanella, G.; Paris, S. Ecogenetics of Parkinson’s disease: Prevalence and environmental aspects in rural areas. Can. J. Neurol. Sci. 1987, 14, 36–41. [Google Scholar] [CrossRef] [PubMed]
  40. Vaccari, C.; El Dib, R.; De Camargo, J.L.V. Paraquat and Parkinson’s disease: A systematic review protocol according to the OHAT approach for hazard identification. Syst. Rev. 2017, 6, 98. [Google Scholar] [CrossRef] [PubMed]
  41. Berry, C.; La Vecchia, C.; Nicotera, P. Paraquat and Parkinson’s disease. Cell Death Differ. 2010, 17, 1115–1125. [Google Scholar] [CrossRef] [PubMed]
  42. Tanner, C.M.; Kamel, F.; Ross, G.W.; Hoppin, J.A.; Goldman, S.M.; Korell, M.; Marras, C.; Bhudhikanok, G.S.; Kasten, M.; Chade, A.R.; et al. Rotenone, paraquat, and Parkinson’s disease. Environ. Health Perspect. 2011, 119, 866–872. [Google Scholar] [CrossRef] [PubMed]
  43. Stentz, L.A.; Tsao, J.W. Endogenous Toxins: Targets for Disease Treatment and Prevention; O’Brien, P.J., Bruce, W.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2010. [Google Scholar]
  44. Smith, M.A.; Taneda, S.; Richey, P.L.; Miyata, S.; Yan, S.D.; Stern, D.; Sayre, L.M.; Monnier, V.M.; Perry, G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 1994, 91, 5710–5714. [Google Scholar] [CrossRef] [PubMed]
  45. Lee, O.; Bruce, W.R.; Dong, Q.; Bruce, J.; Mehta, R.; O’Brien, P.J. Fructose and carbonyl metabolites as endogenous toxins. Chem. Biol. Interact. 2009, 178, 332–339. [Google Scholar] [CrossRef] [PubMed]
  46. Cheng, W.-C.; Kurth, M.J. The Zincke Reaction. A Review. Org. Prep. Proced. Int. 2002, 34, 585–608. [Google Scholar] [CrossRef]
  47. Yamaguchi, I.; Higashi, H.; Shigesue, S.; Shingai, S.; Sato, M. N-Arylated pyridinium salts having reactive groups. Tetrahedron Lett. 2007, 48, 7778–7781. [Google Scholar] [CrossRef]
  48. Nguyen, T.M.; Sanchez-Salvatori, M.d.R.; Wypych, J.-C.; Marazano, C. Aminopentadiene imines from Zincke salts of 3-Alkylpyridines. Application to a synthesis of pyridinium salts from amino acids. J. Org. Chem. 2007, 72, 5916–5919. [Google Scholar] [CrossRef]
  49. Kearney, A.M.; Vanderwal, C.D. Synthesis of nitrogen heterocycles by the ring opening of pyridinium Salts. Angew. Chem. Int. Ed. 2006, 45, 7803–7806. [Google Scholar] [CrossRef]
  50. Viana, G.H.R.; Santos, I.C.; Alves, R.B.; Gil, L.; Marazano, C.; Gil, R.P.F. Microwave-promoted synthesis of chiral pyridinium salts. Tetrahedron Lett. 2005, 46, 7773–7776. [Google Scholar] [CrossRef] [Green Version]
  51. Pernak, J.; Walerowicz, W. Kinetic of Synthesis of Octylthiomethylpyridinium Chloride. Polish J. Chem. 1981, 55, 1109. [Google Scholar]
  52. Pernak, J.; Rogoza, J. Synthesis of 3-substituted pyridinium salts. Arkivoc 2000, 1, 889–904. [Google Scholar]
  53. Balaban, A.T.; Dinculescu, A.; Dorofeenko, G.N.; Fischer, G.W.; Koblik, A.V.; Mezheritskii, V.V.; Schroth, W. Pyrylium Salts. Syntheses, Reactions and Physical Properties. In Advances in Heterocyclic Chemistry; Katritzky, A.R., Ed.; Academic Press: New York, NY, USA, 1982; Volume 2. [Google Scholar]
  54. Balaban, A.T. Aromaticity of six-membered rings with one heteroatom. Top. Heterocycl. Chem. 2008, 19, 203. [Google Scholar]
  55. Charman, H.B.; Rowe, J.M. Condensation of aldehydes with ammonium salts to give substituted pyridines. Chem. Commun. 1971, 10, 476–477. [Google Scholar] [CrossRef]
  56. Dagorn, F.; Yan, L.-H.; Gravel, E.; Leblanc, K.; Maciuk, A.; Poupon, E. Particular behavior of ‘C6C2 units’ in the Chichibabin pyridine synthesis and biosynthetic implications. Tetrahedron Lett. 2011, 52, 3523–3526. [Google Scholar] [CrossRef]
  57. Ma, T.; Zhang, S.; Li, Y.; Yang, F.; Gong, C.; Zhao, J. Synthesis and characterization of soluble polyimides based on a new fluorinated diamine: 4-Phenyl-2,6-bis [3-(4’-amino-2’-trifluoromethyl-phenoxy) phenyl] pyridine. J. Fluor. Chem. 2010, 131, 724–730. [Google Scholar] [CrossRef]
  58. Suyama, K.; Adachi, S. Reaction of alkanals and amino acids or primary amines. Synthesis of 1,2,3,5- and 1,3,4,5-substituted quaternary pyridinium salts. J. Org. Chem. 1979, 44, 1417–1420. [Google Scholar] [CrossRef]
  59. El Kharrat, S.; Laurent, P.; Blancou, H. Novel synthesis, reactivity, and stereochemistry of substituted 3-trifluoromethyl- and 3-perfluoroalkyl-3-phenoxyprop-2-enal. J. Org. Chem. 2006, 71, 6742–6752. [Google Scholar] [CrossRef] [PubMed]
  60. El Kharrat, S.; Laurent, P.; Blancou, H. Novel synthesis of 2-(trifluoromethyl)- and 2-(perfluoroalkyl)-2-hydroxy-2H-chromenes and their regiospecific reaction with silyl enol ethers. J. Org. Chem. 2006, 71, 8637–8640. [Google Scholar] [CrossRef] [PubMed]
  61. El Kharrat, S.; Laurent, P.; Blancou, H. Nouveaux Composés, Leur Preparation et Leur Utilization Pour la Synthèse Régiospécifique D’hétérocycles à Groupement Perfluoroalkylé. French Patent No. B0605WO, 2004. [Google Scholar]
  62. El Kharrat, S.; Laurent, P.; Blancou, H. Novel Compounds, the Preparation and the Use Thereof for a Regiospecific Synthesis of Perfluor(Alkyl) Group Heterocycles. PCT/Patent FR2,005,000,863, 8 April 2005. [Google Scholar]
  63. El Kharrat, S.; Laurent, P.; Blancou, H. The stability/reactivity effects of trifluoromethyl and perfluoroalkyl chains in a masked 1,3-dicarbonyl derivative: The case of 1-acetoxy-1-iodo-2-(perfluoroalkyl)ethanes. Synlett. 2009, 2009, 9–22. [Google Scholar] [CrossRef]
  64. El Kharrat, S.; Skander, M.; Dahmani, A.; Laurent, P.; Blancou, H. New regiospecific synthesis of 2-trifluoromethyl-1,5-diazapentadiene compounds and of 2-trifluoromethylquinolines, their cyclization products. J. Org. Chem. 2005, 70, 8327–8331. [Google Scholar] [CrossRef] [PubMed]
  65. El Kharrat, S.; Laurent, P.; Blancou, H. Synthesis of substituted 1-trifluoromethyl and 1-perfluoroalkyl-3-(arylamino) prop-2-en-1-one: Advances in the mechanism of Combes 2-trifluoromethyl and 2-perfluoroalkyl quinolines synthesis. Tetrahedron 2014, 70, 1252–1266. [Google Scholar] [CrossRef]
  66. Nicolaou, K.C.; Edmonds, D.J.; Bulger, P.G. Cascade reactions in total synthesis. Angew. Chem. Int. Ed. 2006, 45, 7134–7186. [Google Scholar] [CrossRef] [PubMed]
  67. Boger, D.L.; Panek, J.S. Inverse electron demand Diels-Alder reactions of heterocyclic azadienes: Formal total synthesis of streptonigrin. J. Am. Chem. Soc. 1985, 107, 5745–5754. [Google Scholar] [CrossRef]
  68. Boger, D.L.; Coleman, R.S. Total synthesis of (+)-CC-1065 and ent-(−)-CC-1065. J. Am. Chem. Soc. 1988, 110, 1321–1323. [Google Scholar] [CrossRef]
  69. Wasserman, H.H.; DeSimone, R.W.; Boger, D.L.; Baldino, C.M. Singlet oxygen oxidation of bipyrroles: Total synthesis of d,l- and meso-isochrysohermidin. J. Am. Chem. Soc. 1993, 115, 8457–8458. [Google Scholar] [CrossRef]
  70. Palasz, A. Recent advances in inverse-electron-demand hetero-Diels–Alder reactions of 1-oxa-1,3-butadienes. Top. Curr. Chem. 2016, 374, 24. [Google Scholar] [CrossRef] [PubMed]
  71. Bayly, C.I.; Grein, F. Comparison of an intramolecular Michael-type addition with its intermolecular counterpart: An abinitio theoretical study. Can. J. Chem. 1989, 67, 2173–2177. [Google Scholar] [CrossRef]
Sample Availability: Samples of the compounds are available from the authors.
Scheme 1. Structure of 1-methyl-4-phenylpyridinium (MPP+) 1 and pyridinium furosemide 2 correlated to neurodegeneration.
Scheme 1. Structure of 1-methyl-4-phenylpyridinium (MPP+) 1 and pyridinium furosemide 2 correlated to neurodegeneration.
Molecules 24 02328 sch001
Scheme 2. Synthetic routes to N-(hetero)arylpyridinium salts 6 and N-alkylpyridinium salts 7 starting from pyridines 3 or pyryliums 8 [46,47,48,49,50,51,52,53,54]. R’: alkyl, arylakyl; X: halides, sulfonates; R: electron-donor substituents, X: halides.
Scheme 2. Synthetic routes to N-(hetero)arylpyridinium salts 6 and N-alkylpyridinium salts 7 starting from pyridines 3 or pyryliums 8 [46,47,48,49,50,51,52,53,54]. R’: alkyl, arylakyl; X: halides, sulfonates; R: electron-donor substituents, X: halides.
Molecules 24 02328 sch002
Scheme 3. Pyridinium synthetic routes through the Chichibabine reaction [55,56,57,58].
Scheme 3. Pyridinium synthetic routes through the Chichibabine reaction [55,56,57,58].
Molecules 24 02328 sch003
Scheme 4. Synthesis (optimized stoichiometries) of trifluoromethylated and perfluoroalkylated 6-methyl-N-arylpyridiniums 17an’, N-aryl-5,6,7,8-tetrahydroquinoliniums 18a–n and N-aryl-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums 19am, examples in Table 1, Table 2 and Table 3 respectively (bottom right: structures of compound series 1719).
Scheme 4. Synthesis (optimized stoichiometries) of trifluoromethylated and perfluoroalkylated 6-methyl-N-arylpyridiniums 17an’, N-aryl-5,6,7,8-tetrahydroquinoliniums 18a–n and N-aryl-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums 19am, examples in Table 1, Table 2 and Table 3 respectively (bottom right: structures of compound series 1719).
Molecules 24 02328 sch004
Figure 1. Structure of 6-methyl-2-perfluoropentyl-1-phenylpyridinium 17a and NMR resonance assignments.
Figure 1. Structure of 6-methyl-2-perfluoropentyl-1-phenylpyridinium 17a and NMR resonance assignments.
Molecules 24 02328 g001
Scheme 5. Formation of 2-perfluoroalkyl-7-methoxyquinolines 20oo’ in the case of aniline 15o (R = m-OMe), in the presence or absence of ketone 16; examples in Table 4.
Scheme 5. Formation of 2-perfluoroalkyl-7-methoxyquinolines 20oo’ in the case of aniline 15o (R = m-OMe), in the presence or absence of ketone 16; examples in Table 4.
Molecules 24 02328 sch005
Scheme 6. Synthesis of N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapentadienes intermediates 21ao’, and further formation of 2-trifluoromethyl and 2-perfluoroalkyl-N-arylpyridinium derivatives 1719 or 2-perfluoroalkyl-7-methoxyquinoline 20.
Scheme 6. Synthesis of N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapentadienes intermediates 21ao’, and further formation of 2-trifluoromethyl and 2-perfluoroalkyl-N-arylpyridinium derivatives 1719 or 2-perfluoroalkyl-7-methoxyquinoline 20.
Molecules 24 02328 sch006
Scheme 7. Diels-Alder/Aza-Robinson bis-de-anilino-elimination cascade mechanism hypotheses of formation 2-trifluoromethyl and 2-perfluoroalkyl-N-arylpyridiniums 1719. BATHP: bis-anilino-tetrahydropyridine.
Scheme 7. Diels-Alder/Aza-Robinson bis-de-anilino-elimination cascade mechanism hypotheses of formation 2-trifluoromethyl and 2-perfluoroalkyl-N-arylpyridiniums 1719. BATHP: bis-anilino-tetrahydropyridine.
Molecules 24 02328 sch007
Scheme 8. Proposed mechanism of formation of 20o/o’ from 21o/o’ [59,64].
Scheme 8. Proposed mechanism of formation of 20o/o’ from 21o/o’ [59,64].
Molecules 24 02328 sch008
Table 1. Reaction conditions and conversions for the synthesis of substituted 2-trifluoromethyl-/2-perfluoroalkyl-N-arylpyridinium compounds 17an’, using acetone 16t as reactant.
Table 1. Reaction conditions and conversions for the synthesis of substituted 2-trifluoromethyl-/2-perfluoroalkyl-N-arylpyridinium compounds 17an’, using acetone 16t as reactant.
Molecules 24 02328 i001
Entry1415TimePyridiniums 17Conv.
RF R(h) [%]a
114C5F1115aH417a95
214’CF315aH417a’95
314’’C3F715aH417a’’95
414C5F1115bo-Me617b80
514C5F1115cm-Me417c85
614C5F1115dp-Me417d88
714’CF315dp-Me417d’88
814C5F1115eo-Et617e75
914C5F1115fm-Et417f80
1014C5F1115gp-Et417g83
1114’CF315gp-Et417g’85
1214C5F1115ho-Cl1217h65
1314C5F1115im-Cl617i75
1414C5F1115jp-Cl617j83
1514C5F1115ko-OMe617k75
1614C5F1115lp-OMe417l78
1714C5F1115mo-CO2H1217m50
1814’CF315mo-CO2H1217m’52
1914C5F1115np-CO2H1217n60
2014’CF315np-CO2H1217n’62
a Determined by 19F-NMR analysis; NMR yield based on consumed 14 and formed 17.
Table 2. Reaction conditions and conversions for the preparation of substituted 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-5,6,7,8-tetrahydroquinoliniums 18an, using cyclohexanone 16u as reactant.
Table 2. Reaction conditions and conversions for the preparation of substituted 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-5,6,7,8-tetrahydroquinoliniums 18an, using cyclohexanone 16u as reactant.
Molecules 24 02328 i002
Entry1415TimePyridiniums 18Conv.
RF R(h)[%]a
114C5F1115aH418a85
214’CF315aH418a’88
314C5F1115bo-Me618b85
414C5F1115cm-Me418c85
514C5F1115dp-Me418d85
614C5F1115gp-Et418g86
714C5F1115im-Cl618i78
814C5F1115lp-OMe618l90
914C5F1115mo-CO2H1218m75
1014C5F1115np-CO2H1218n75
a Determined by 19F-NMR analysis; NMR yield based on consumed 14 and formed 18.
Table 3. Reaction conditions and conversions for the preparation of 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums 19am, using cyclo-heptanone 16v as reactant.
Table 3. Reaction conditions and conversions for the preparation of 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums 19am, using cyclo-heptanone 16v as reactant.
Molecules 24 02328 i003
Entry1415TimePyridiniums 19Conv.
RF R(h)[%]a
114C5F1115aH419a85
214C5F1115cm-Me419c83
314C5F1115dp-Me419d85
414C5F1115fm-Et419f88
514C5F1115gp-Et419g85
614C5F1115im-Cl419i70
714C5F1115jp-Cl419j78
814C5F1115ko-OMe619k72
914C5F1115lp-OMe419l88
1014C5F1115mo-CO2H1219m70
a Determined by 19F-NMR analysis; NMR yield based on consumed 14 and formed 19.
Table 4. Reaction conditions and conversions obtained for the formation of substituted 2-perfluoropentyl-/2-trifluoromethyl-7-methoxyquinolines (20oo’), starting from m-anisidine 15o, with or without ketone 16tv.
Table 4. Reaction conditions and conversions obtained for the formation of substituted 2-perfluoropentyl-/2-trifluoromethyl-7-methoxyquinolines (20oo’), starting from m-anisidine 15o, with or without ketone 16tv.
Molecules 24 02328 i004
Entry1416TimeConv.Quinolines 20
RF (h)[%]a
114C5F1116t128520o
214C5F1116u1280
314C5F1116v1282
414C5F11-1286
514’CF316t129020o’
614’CF3-1292
a Determined by 19F-NMR analysis; NMR yield based on consumed 14 and formed 19.

Share and Cite

MDPI and ACS Style

El Kharrat, S.; Laurent, P.; Boiteau, L.; Blancou, H. Novel Synthesis of Substituted 2-Trifluoromethyl and 2-Perfluoroalkyl N-Arylpyridinium Compounds—Mechanistic Insights. Molecules 2019, 24, 2328. https://doi.org/10.3390/molecules24122328

AMA Style

El Kharrat S, Laurent P, Boiteau L, Blancou H. Novel Synthesis of Substituted 2-Trifluoromethyl and 2-Perfluoroalkyl N-Arylpyridinium Compounds—Mechanistic Insights. Molecules. 2019; 24(12):2328. https://doi.org/10.3390/molecules24122328

Chicago/Turabian Style

El Kharrat, Salem, Philippe Laurent, Laurent Boiteau, and Hubert Blancou. 2019. "Novel Synthesis of Substituted 2-Trifluoromethyl and 2-Perfluoroalkyl N-Arylpyridinium Compounds—Mechanistic Insights" Molecules 24, no. 12: 2328. https://doi.org/10.3390/molecules24122328

Article Metrics

Back to TopTop